array:23 [
  "pii" => "S0014256517300978"
  "issn" => "00142565"
  "doi" => "10.1016/j.rce.2017.02.017"
  "estado" => "S300"
  "fechaPublicacion" => "2017-08-01"
  "aid" => "1386"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "fla"
  "cita" => "Rev Clin Esp. 2017;217:359-64"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 130
    "formatos" => array:2 [
      "HTML" => 79
      "PDF" => 51
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S225488741730053X"
      "issn" => "22548874"
      "doi" => "10.1016/j.rceng.2017.04.003"
      "estado" => "S300"
      "fechaPublicacion" => "2017-08-01"
      "aid" => "1386"
      "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "fla"
      "cita" => "Rev Clin Esp. 2017;217:359-64"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 2
        "PDF" => 2
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">For and against</span>"
        "titulo" => "Extended anticoagulation in venous thromboembolism disease&#46; In favor"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "es"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "359"
            "paginaFinal" => "364"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Anticoagulaci&#243;n extendida en la enfermedad tromboemb&#243;lica venosa&#46; A favor"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "M&#46;C&#46; Fern&#225;ndez"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "M&#46;C&#46;"
                "apellidos" => "Fern&#225;ndez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0014256517300978"
          "doi" => "10.1016/j.rce.2017.02.017"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256517300978?idApp=WRCEE"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S225488741730053X?idApp=WRCEE"
      "url" => "/22548874/0000021700000006/v1_201707280038/S225488741730053X/v1_201707280038/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0014256517300759"
    "issn" => "00142565"
    "doi" => "10.1016/j.rce.2017.02.012"
    "estado" => "S300"
    "fechaPublicacion" => "2017-08-01"
    "aid" => "1380"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Medicina Interna &#40;SEMI&#41;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Rev Clin Esp. 2017;217:365-9"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 148
      "formatos" => array:2 [
        "HTML" => 88
        "PDF" => 60
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">PROS Y CONTRAS</span>"
      "titulo" => "Duraci&#243;n del tratamiento anticoagulante&#46; A favor de plazos cortos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "365"
          "paginaFinal" => "369"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Anticoagulant therapy duration&#46; In favour of short-term courses"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1837
              "Ancho" => 2344
              "Tamanyo" => 125585
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Acontecimientos adversos durante el seguimiento en pacientes con enfermedad tromoboemb&#243;lica venosa&#44; tratados&#46; Incidencia de fallecimientos por embolia pulmonar &#40;l&#237;neas negras&#41; y hemorragia &#40;l&#237;neas claras&#41; en 53&#46;222 pacientes diagnosticados de embolia pulmonar y trombosis venosa profunda&#44; a partir del tercer mes despu&#233;s del diagn&#243;stico&#46;</p> <p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Las muertes por hemorragia en todo momento superan a las de embolia pulmonar&#46; Para una comparaci&#243;n m&#225;s ajustada&#44; al n&#250;mero de fallecimientos por hemorragia hay que restar 0&#44;14&#37; &#40;0&#44;06-0&#44;26&#37;&#41; de fallecimientos anuales que ocurrir&#237;an si estos pacientes no estuvieran anticoagulados&#46;</p> <p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">EP&#58; embolia pulmonar&#59; TVP&#58; trombosis venosa profunda&#46;</p> <p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Fuente&#58; registro RIETE &#40;datos no publicados&#41; y Castellucci et al&#46;<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">21</span></a>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46;A&#46; Nieto Rodr&#237;guez, J&#46;C&#46; Ram&#237;rez Luna"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "J&#46;A&#46;"
              "apellidos" => "Nieto Rodr&#237;guez"
            ]
            1 => array:2 [
              "nombre" => "J&#46;C&#46;"
              "apellidos" => "Ram&#237;rez Luna"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2254887417300401"
        "doi" => "10.1016/j.rceng.2017.04.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887417300401?idApp=WRCEE"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256517300759?idApp=WRCEE"
    "url" => "/00142565/0000021700000006/v1_201707280054/S0014256517300759/v1_201707280054/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0014256517301017"
    "issn" => "00142565"
    "doi" => "10.1016/j.rce.2017.03.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-08-01"
    "aid" => "1390"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Medicina Interna &#40;SEMI&#41;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "ssu"
    "cita" => "Rev Clin Esp. 2017;217:351-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 260
      "formatos" => array:2 [
        "HTML" => 154
        "PDF" => 106
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Simposio&#46; Pluripatolog&#237;a</span>"
      "titulo" => "Modelos de atenci&#243;n al paciente pluripatol&#243;gico"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "351"
          "paginaFinal" => "358"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Care models for polypathological patients"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1120
              "Ancho" => 2498
              "Tamanyo" => 168493
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">El modelo de cuidados de pacientes con enfermedades cr&#243;nicas&#46;</p> <p id="spar0020" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Fuente&#58; Cuidados innovadores para las condiciones cr&#243;nicas&#58; organizaci&#243;n y prestaci&#243;n de atenci&#243;n de alta calidad a las enfermedades cr&#243;nicas no transmisibles en las Am&#233;ricas</span>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "A&#46; Fern&#225;ndez Moyano, J&#46;M&#46; Mach&#237;n L&#225;zaro, M&#46;D&#46; Mart&#237;n Escalante, M&#46;B&#46; Aller Hernandez, I&#46; Vallejo Maroto"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Fern&#225;ndez Moyano"
            ]
            1 => array:2 [
              "nombre" => "J&#46;M&#46;"
              "apellidos" => "Mach&#237;n L&#225;zaro"
            ]
            2 => array:2 [
              "nombre" => "M&#46;D&#46;"
              "apellidos" => "Mart&#237;n Escalante"
            ]
            3 => array:2 [
              "nombre" => "M&#46;B&#46;"
              "apellidos" => "Aller Hernandez"
            ]
            4 => array:2 [
              "nombre" => "I&#46;"
              "apellidos" => "Vallejo Maroto"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S225488741730067X"
        "doi" => "10.1016/j.rceng.2017.05.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S225488741730067X?idApp=WRCEE"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256517301017?idApp=WRCEE"
    "url" => "/00142565/0000021700000006/v1_201707280054/S0014256517301017/v1_201707280054/es/main.assets"
  ]
  "es" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Pros y Contras</span>"
    "titulo" => "Anticoagulaci&#243;n extendida en la enfermedad tromboemb&#243;lica venosa&#46; A favor"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "359"
        "paginaFinal" => "364"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "M&#46;C&#46; Fern&#225;ndez Capitan"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "M&#46;C&#46;"
            "apellidos" => "Fern&#225;ndez Capitan"
            "email" => array:1 [
              0 => "mfcapitan&#64;salud&#46;madrid&#46;org"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Medicina Interna&#44; Hospital Universitario La Paz&#44; Madrid&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Extended anticoagulation in venous thromboembolism disease&#46; In favour"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">La enfermedad tromboemb&#243;lica venosa &#40;ETEV&#41; es una enfermedad grave que&#44; a pesar de los avances diagn&#243;sticos y terap&#233;uticos&#44; mantiene una mortalidad elevada &#40;13&#37;&#41; y produce secuelas importantes como la hipertensi&#243;n pulmonar &#40;3&#37; anual&#41;&#44; o el s&#237;ndrome postromb&#243;tico &#40;SPT&#41; &#40;30&#37; en 8 a&#241;os&#41;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;2</span></a>&#46; La ETEV puede considerarse una enfermedad cr&#243;nica ya que&#44; despu&#233;s de un primer episodio&#44; el riesgo anual de recurrencia es del 2-3&#44;8&#37;&#44; alcanzando el 30-50&#37; en 10 a&#241;os&#44; con una mortalidad asociada del 3-18&#37;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3-5</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Las gu&#237;as de pr&#225;ctica cl&#237;nica<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6&#44;7</span></a> recomiendan realizar tratamiento anticoagulante de duraci&#243;n limitada en la mayor&#237;a de pacientes con ETEV&#44; pero el alto riesgo de recurrencia hace que muchos requieran su prolongaci&#243;n<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a>&#46; Aunque la anticoagulaci&#243;n prolongada es eficaz&#44; el riesgo de recurrencia permanece cuando se retira y se desconoce cu&#225;l debe ser la duraci&#243;n &#243;ptima del tratamiento<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a>&#46; Por lo tanto&#44; la decisi&#243;n m&#225;s dif&#237;cil en la ETEV no es la de anticoagular&#44; ni a qui&#233;n&#44; o qu&#233; tratamiento utilizar&#44; sino cu&#225;ndo suspender los anticoagulantes a un paciente despu&#233;s de un tiempo limitado de tratamiento&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">En la gu&#237;a del <span class="elsevierStyleItalic">American College of Chest Physicians</span> &#40;ACCP&#41;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> se sugiere&#44; como duraci&#243;n m&#225;s adecuada de tratamiento con diferentes grados de recomendaci&#243;n basados en la evidencia&#44; 3 meses en los pacientes con ETEV &#171;provocada&#187;&#46; Asimismo&#44; se recomienda prolongar la anticoagulaci&#243;n&#44; sin fecha programada de finalizaci&#243;n &#40;&#171;anticoagulaci&#243;n extendida&#187;&#41;&#44; en aquellos pacientes con ETEV idiop&#225;tica de repetici&#243;n o asociada a c&#225;ncer&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">La duda fundamental para extender la anticoagulaci&#243;n surge en los pacientes que han sufrido un primer episodio de ETEV no provocada&#44; sobre todo en aquellos sin riesgo elevado de sangrado<span class="elsevierStyleBold">&#46;</span> No existe una regla de predicci&#243;n cl&#237;nica que clasifique a estos pacientes y la decisi&#243;n&#44; siempre dif&#237;cil&#44; se basa en una cuidadosa valoraci&#243;n del riesgo y el beneficio de la anticoagulaci&#243;n&#59; beneficio de evitar una recurrencia y sus consecuencias&#44; y riesgo de hemorragia&#44; sobre todo la temida hemorragia intracraneal&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">La decisi&#243;n de mantener la anticoagulaci&#243;n debe fundarse principalmente en el riesgo de recurrencia&#44; ya que el riesgo de hemorragia es secundario&#44; dif&#237;cil de predecir y debe asumirse cuando el primero es elevado&#46; En cualquier caso&#44; antes de tomar una decisi&#243;n definitiva es necesario facilitar una informaci&#243;n clara y compresible al paciente y tener en cuenta su opini&#243;n&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Riesgo de recurrencia y de hemorragia</span><p id="par0030" class="elsevierStylePara elsevierViewall">El riesgo de recurrencia se mantiene a lo largo de toda la vida del paciente y&#44; aunque es mayor en el caso de ETEV idiop&#225;tica&#44; tambi&#233;n existe cuando hay factores de riesgo &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Para facilitar la decisi&#243;n terap&#233;utica se han buscado factores que puedan ayudar a estratificar el riesgo de recurrencia&#44; como el g&#233;nero del paciente y la concentraci&#243;n de d&#237;mero D medido un mes despu&#233;s de suspender la anticoagulaci&#243;n&#46; Los hombres tienen un riesgo de recidiva 1&#44;75 veces mayor que las mujeres&#44; y los pacientes con d&#237;mero D elevado el doble que los que lo tienen normal<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9-11</span></a>&#46; Tambi&#233;n se han utilizado otros factores como la edad &#40;&#60;<span class="elsevierStyleHsp" style=""></span>50 a&#241;os&#41;&#44; la persistencia de trombosis venosa &#40;&#62;<span class="elsevierStyleHsp" style=""></span>40&#37; de la luz obstruida&#44; riesgo relativo &#91;RR&#93; 1&#44;5&#41;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a>&#44; la trombofilia &#40;RR&#58; 1&#44;5&#59; s&#237;ndrome antifosfol&#237;pido RR&#58; 2&#41;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> o el SPT&#46; Por &#250;ltimo&#44; es importante considerar la forma de expresi&#243;n cl&#237;nica inicial de la ETEV&#46; Los pacientes con trombosis venosa profunda &#40;TVP&#41; distal tienen un riesgo de recurrencia 5 veces menor que aquellos con TVP proximal y&#44; por otra parte&#44; en los pacientes con embolia pulmonar &#40;EP&#41; el riesgo de que la recurrencia se manifieste como un nuevo episodio de EP se multiplica por 3&#44; con el consiguiente aumento de mortalidad<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14&#44;15</span></a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">Muchos de estos factores se han recogido en escalas de predicci&#243;n de la recidiva<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11-16&#44;17</span></a>&#46; Un riesgo de recurrencia menor del 5&#37; al a&#241;o o del 15&#37; a los 5 a&#241;os se considera aceptable y justificar&#237;a suspender la anticoagulaci&#243;n despu&#233;s de 3 meses de tratamiento&#46; Sin embargo&#44; la falta de validaci&#243;n de estos factores hace que no existan recomendaciones firmes sobre su utilizaci&#243;n para decidir el tiempo de anticoagulaci&#243;n tras una primera ETEV idiop&#225;tica<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a>&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Tambi&#233;n existen escalas para estimar el riesgo de hemorragia&#44; inherente al tratamiento anticoagulante&#44; en funci&#243;n de la existencia de diversos factores&#46; Nuevamente&#44; el hecho de estar basadas en estudios realizados en pacientes anticoagulados por otras causas o en pacientes con ETEV durante un tratamiento de duraci&#243;n prefijada&#44; limita su utilidad en la valoraci&#243;n de extender la anticoagulaci&#243;n&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Balance del riesgo-beneficio de extender la anticoagulaci&#243;n</span><p id="par0045" class="elsevierStylePara elsevierViewall">La consecuencia m&#225;s grave de una recurrencia o de una hemorragia es la muerte del paciente&#46; La tasa global de mortalidad por ETEV recurrente es del 3&#44;6&#37; &#40;1&#44;9-5&#44;7&#37;&#41;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3-5</span></a>&#46; La tasa de mortalidad por hemorragia var&#237;a a lo largo del tiempo&#46; Seg&#250;n un metaan&#225;lisis&#44; en los 3 primeros meses de anticoagulaci&#243;n la tasa de hemorragia mayor es del 2&#44;06&#37; &#40;2&#44;04-2&#44;08&#37;&#41; y la de hemorragia mortal es del 0&#44;37&#37; &#40;0&#44;36-0&#44;38&#37;&#41;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a>&#44; similar a lo observado en pacientes del &#171;Registro Informatizado de pacientes con Enfermedad TromboEmb&#243;lica&#187; &#40;RIETE&#41;&#44; con cifras respectivas del 2&#44;2 y 0&#44;56&#37;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a>&#46; Despu&#233;s de 3 meses estas tasas son del 2&#44;74 y 0&#44;63&#37;&#44; respectivamente<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a>&#46; Muchos de estos datos proceden de estudios retrospectivos y ensayos cl&#237;nicos realizados en pacientes seleccionados o que reciben anticoagulaci&#243;n durante un tiempo limitado&#44; por lo que infraestiman la incidencia real de recurrencia&#44; y su validez para decidir la prolongaci&#243;n o no del tratamiento es cuestionable<span class="elsevierStyleItalic">&#46;</span> Adem&#225;s&#44; es importante considerar que las recurrencias no mortales tambi&#233;n son importantes&#44; ya que pueden producir un SPT y un deterioro cr&#243;nico y progresivo de la situaci&#243;n cardiopulmonar del paciente&#44; con el consiguiente coste emocional&#44; social y econ&#243;mico&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Los estudios realizados<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5&#44;21</span></a> para comparar diferentes duraciones de tratamiento en pacientes con un primer episodio de ETEV que hab&#237;an completado 6 meses de tratamiento demostraron que los f&#225;rmacos antivitamina K &#40;AVK&#41;&#44; con un objetivo terap&#233;utico seg&#250;n una raz&#243;n internacional normalizada &#40;INR&#41; de 2&#44;5 &#40;entre 2 y 3&#41;&#44; fueron muy eficaces para prevenir nuevos eventos tromb&#243;ticos&#46; Sin embargo&#44; tras suspender la anticoagulaci&#243;n&#44; el riesgo de recurrencias fue igual para los tratados durante 6 o 24 meses<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a>&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Los estudios<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10&#44;22&#44;23</span></a> que compararon la prolongaci&#243;n de la anticoagulaci&#243;n con AVK durante m&#225;s de 3 meses con la suspensi&#243;n del tratamiento en los pacientes con ETEV idiop&#225;tica han demostrado que la anticoagulaci&#243;n a largo plazo reduce las recurrencias en un 90&#37;&#46; Al igual que en otros estudios&#44; estas fueron elevadas en los pacientes sin tratamiento extendido&#44; estim&#225;ndose en un 10&#37; el primer a&#241;o&#44; un 30&#37; a los 5 a&#241;os y hasta un 50&#37; a los 10 a&#241;os<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2&#44;22-25</span></a>&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">El riesgo de hemorragia mayor aument&#243; durante la anticoagulaci&#243;n extendida &#40;1-2&#37; al a&#241;o&#44; RR&#58; 1&#44;8&#59; intervalo de confianza &#91;IC&#93; del 95&#37;&#58; 0&#44;7-4&#44;5&#41;<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#44; siendo solo la mitad de los sangrados atribuibles al tratamiento<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#46; La frecuencia acumulada de la variable compuesta &#171;ETEV recurrente y hemorragia mayor&#187; fue mucho menor en los pacientes que permanecieron anticoagulados<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;23-26</span></a>&#44; y el beneficio&#44; mayor cuanto m&#225;s prolongado el seguimiento<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Alrededor del 10&#37; de las hemorragias mayores durante el tratamiento extendido son mortales<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a>&#44; mientras que la mortalidad por recurrencia es aproximadamente del 5&#37; en el caso de la TVP y del 15-18&#37; en la EP<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5&#44;25&#44;27</span></a>&#46; Sin embargo&#44; aunque la mortalidad por hemorragias puede ser mayor que la debida a recurrencias&#44; el gran n&#250;mero de recurrencias supera las consecuencias del aumento de hemorragias si se prolonga la anticoagulaci&#243;n&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Por otra parte&#44; debemos considerar que las tasas de hemorragia y recurrencia en pacientes con AVK se relacionan con el grado de control de la anticoagulaci&#243;n&#44; siendo m&#225;s bajas en aquellos con un tiempo dentro del rango terap&#233;utico &#40;TTR&#41; &#8805;<span class="elsevierStyleHsp" style=""></span>70&#37; &#40;RR&#58; 0&#44;50&#59; IC 95&#37;&#58; 0&#44;39-0&#44;63&#41; comparado con aquellos con TTR &#60;<span class="elsevierStyleHsp" style=""></span>30&#37;<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a>&#46; Por todo esto&#44; el reto actual se focaliza en elegir el f&#225;rmaco m&#225;s eficaz y seguro para extender la anticoagulaci&#243;n&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Reducci&#243;n de la enfermedad tromboemb&#243;lica venosa recurrente con anticoagulaci&#243;n extendida&#46; Eficacia</span><p id="par0075" class="elsevierStylePara elsevierViewall">La anticoagulaci&#243;n extendida con AVK reduce la ETEV recurrente en un 90&#37; &#40;RR&#58; 0&#44;12&#59; IC 95&#37;&#58; 0&#44;05-0&#44;25&#41;&#44; sucediendo la mitad de las recurrencias en los pacientes que suspendieron prematuramente el tratamiento<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a>&#46; Adem&#225;s&#44; este tratamiento reduce en un 50&#37; el resultado combinado de &#171;ETEV recurrente&#44; hemorragia mayor y muerte&#187; en comparaci&#243;n con la ausencia de anticoagulaci&#243;n<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#46; Estos resultados avalan la eficacia del tratamiento prolongado<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">23&#44;29</span></a>&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">Se han demostrado reducciones similares de recurrencia &#40;&#62;<span class="elsevierStyleHsp" style=""></span>80-92&#37;&#41; con anticoagulaci&#243;n extendida utilizando anticoagulantes orales de acci&#243;n directa &#40;ACOD&#41; frente a placebo<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30-32</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">tabla 2</a>&#41;&#46; Las heparinas de bajo peso molecular &#40;HBPM&#41; son tambi&#233;n muy eficaces<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">33</span></a>&#44; especialmente en pacientes con c&#225;ncer&#44; en quienes son preferibles al empleo de AVK<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">34</span></a>&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Reducci&#243;n de la hemorragia mayor con anticoagulaci&#243;n extendida&#46; Seguridad</span><p id="par0085" class="elsevierStylePara elsevierViewall">La anticoagulaci&#243;n con AVK se asocia con un aumento del riesgo de hemorragia mayor &#40;RR&#58; 2&#44;63&#59; IC 95&#37;&#58; 1&#44;02-6&#44;78&#41;<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">35</span></a>&#46; Los ACOD se han comparado con AVK para el tratamiento extendido de la ETEV<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30-36</span></a> y han demostrado ser igualmente eficaces&#44; pero m&#225;s seguros&#44; ya que se asocian con menos hemorragias mayores&#44; con la mitad de hemorragias intracraneales y una reducci&#243;n m&#225;s peque&#241;a de hemorragia extracraneal&#46; Por tanto&#44; aunque el tipo de anticoagulante no debe ser decisorio en la elecci&#243;n de la duraci&#243;n del tratamiento&#44; los ACOD suponen una alternativa m&#225;s segura para la prolongaci&#243;n de la anticoagulaci&#243;n &#40;<a class="elsevierStyleCrossRef" href="#tbl0015">tabla 3</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">Se han investigado otros f&#225;rmacos no anticoagulantes en la prevenci&#243;n de recurrencias de ETEV&#44; como el &#225;cido acetilsalic&#237;lico &#40;AAS&#41;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> y la sulodexida<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a>&#46; La eficacia ha sido menor&#44; con una reducci&#243;n de recurrencias del 30 y 50&#37;&#44; respectivamente&#59; y en el caso del AAS&#44; con tasas de hemorragia similares a las de algunos de los ACOD<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a>&#46; Por ello&#44; no son una alternativa para los pacientes sin contraindicaci&#243;n para la anticoagulaci&#243;n&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">&#191;Anticoagulaci&#243;n extendida&#63; A favor</span><p id="par0095" class="elsevierStylePara elsevierViewall">La decisi&#243;n m&#225;s dif&#237;cil en la ETEV no es la de anticoagular&#44; ni a qui&#233;n&#44; o qu&#233; tratamiento utilizar&#44; sino cu&#225;ndo suspender los anticoagulantes a un paciente despu&#233;s de un tiempo limitado de tratamiento&#46; Antes de decidir finalizar o extender la anticoagulaci&#243;n a un paciente con ETEV debemos recordar que&#58;<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">-</span><p id="par0100" class="elsevierStylePara elsevierViewall">El riesgo de recurrencia de trombosis se mantiene toda la vida del paciente y&#44; aunque es mayor en la ETEV idiop&#225;tica&#44; tambi&#233;n existe en la &#171;provocada&#187;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">-</span><p id="par0105" class="elsevierStylePara elsevierViewall">La tasa de mortalidad por recurrencia de ETEV es del 3-18&#37;&#46; Las recurrencias no mortales tambi&#233;n son relevantes &#40;SPT&#44; insuficiencia cardiaca y respiratoria&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">-</span><p id="par0110" class="elsevierStylePara elsevierViewall">El riesgo de hemorragia &#40;principal obst&#225;culo para mantener la anticoagulaci&#243;n&#41; es secundario&#44; por ser dif&#237;cil de predecir y por tener que asumirse cuando el riesgo de recurrencia es elevado&#46;</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">-</span><p id="par0115" class="elsevierStylePara elsevierViewall">La reducci&#243;n de ETEV recurrente con AVK &#40;90&#37;&#41;<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> avala la eficacia del tratamiento anticoagulante prolongado&#46;</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">-</span><p id="par0120" class="elsevierStylePara elsevierViewall">Se han objetivado reducciones similares de las recurrencias &#40;&#62;<span class="elsevierStyleHsp" style=""></span>80-92&#37;&#41; con anticoagulaci&#243;n extendida con ACOD<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30-32</span></a>&#46;</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">-</span><p id="par0125" class="elsevierStylePara elsevierViewall">En los pacientes en tratamiento con AVK el riesgo de recurrencia y de hemorragia se relaciona con el mal control de la anticoagulaci&#243;n&#46;</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">-</span><p id="par0130" class="elsevierStylePara elsevierViewall">En el tratamiento extendido los ACOD han demostrado ser igualmente eficaces que los AVK&#44; pero m&#225;s seguros &#40;menos hemorragias mayores y menos intracraneales&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">-</span><p id="par0135" class="elsevierStylePara elsevierViewall">Los ACOD no necesitan ajuste de dosis y disminuyen otros inconvenientes de la anticoagulaci&#243;n con AVK &#40;p&#46; ej&#46;&#44; control de laboratorio&#44; interacci&#243;n con f&#225;rmacos y alimentos&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">-</span><p id="par0140" class="elsevierStylePara elsevierViewall">No existen f&#225;rmacos alternativos a los anticoagulantes tan eficaces en la prevenci&#243;n de recurrencias que est&#233;n exentos de riesgo hemorr&#225;gico&#46;</p></li></ul></p><p id="par0145" class="elsevierStylePara elsevierViewall">Por &#250;ltimo&#44; es importante recordar que la elecci&#243;n de prolongar la anticoagulaci&#243;n debe individualizarse siempre en funci&#243;n de las caracter&#237;sticas del paciente&#46; La decisi&#243;n de proceder a una &#171;anticoagulaci&#243;n extendida&#187; no es sin&#243;nimo de &#171;anticoagulaci&#243;n para siempre&#187;&#46; En todos los pacientes que reciben anticoagulaci&#243;n prolongada se debe reevaluar peri&#243;dicamente el riesgo y beneficio de continuar con el tratamiento&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conflicto de intereses</span><p id="par0150" class="elsevierStylePara elsevierViewall">La autora declara no tener ning&#250;n conflicto de intereses&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:11 [
        0 => array:3 [
          "identificador" => "xres875395"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec863567"
          "titulo" => "Palabras clave"
        ]
        2 => array:3 [
          "identificador" => "xres875394"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec863566"
          "titulo" => "Keywords"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Riesgo de recurrencia y de hemorragia"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Balance del riesgo-beneficio de extender la anticoagulaci&#243;n"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Reducci&#243;n de la enfermedad tromboemb&#243;lica venosa recurrente con anticoagulaci&#243;n extendida&#46; Eficacia"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Reducci&#243;n de la hemorragia mayor con anticoagulaci&#243;n extendida&#46; Seguridad"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "&#191;Anticoagulaci&#243;n extendida&#63; A favor"
        ]
        9 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Conflicto de intereses"
        ]
        10 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2017-01-02"
    "fechaAceptado" => "2017-02-23"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec863567"
          "palabras" => array:6 [
            0 => "Enfermedad tromboemb&#243;lica venosa"
            1 => "No provocado"
            2 => "Recurrencia"
            3 => "Hemorragia"
            4 => "Anticoagulaci&#243;n extendida"
            5 => "Anticoagulantes"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec863566"
          "palabras" => array:6 [
            0 => "Venous thromboembolism disease"
            1 => "Unprovoked"
            2 => "Recurrence"
            3 => "Haemorrhage"
            4 => "Extended anticoagulation"
            5 => "Anticoagulants"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La enfermedad tromboemb&#243;lica venosa puede considerarse una enfermedad cr&#243;nica ya que&#44; tras un primer episodio&#44; el riesgo de recurrencia permanece toda la vida&#46; La recurrencia es una complicaci&#243;n grave&#46; La anticoagulaci&#243;n es eficaz mientras se mantiene&#44; pero al suspenderla el riesgo de nuevos eventos tromb&#243;ticos persiste indefinidamente&#46; Las gu&#237;as de pr&#225;ctica cl&#237;nica ofrecen recomendaciones espec&#237;ficas sobre la duraci&#243;n del tratamiento en pacientes con enfermedad provocada o recurrente&#44; pero son poco precisas para aquellos con un primer episodio no provocado&#46; La decisi&#243;n debe tomarse tras una cuidadosa valoraci&#243;n individual del riesgo-beneficio de la anticoagulaci&#243;n&#46; Este art&#237;culo repasa las evidencias a favor de prolongar la anticoagulaci&#243;n y las opciones terap&#233;uticas actuales&#46;</p></span>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Venous thromboembolism disease can be considered a chronic disease because&#44; after the first episode&#44; there is a life-long risk of recurrence&#46; Recurrence is a severe complication&#46; Anticoagulation is effective while it is maintained&#44; but when it is discontinued&#44; the risk of new thrombotic events persists indefinitely&#46; Clinical practice guidelines offer specific recommendations on the treatment duration for patients with provoked or recurrent disease but are not specific for those with a first unprovoked episode&#46; The decision should be made after a careful individual assessment of the risk-benefit of anticoagulation&#46; This article reviews the evidence in favour of extending the anticoagulation and the current therapeutic options&#46;</p></span>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:2 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Riesgo general de recurrencia estimado<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">en 5 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pacientes con ETEV &#40;TVP proximal o EP&#41; provocada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Mujeres con d&#237;mero-D negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Varones con d&#237;mero-D negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pacientes con ETEV &#40;TVP proximal o EP&#41; idiop&#225;tica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">30&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1477609.png"
              ]
            ]
            1 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Riesgo general de recurrencia estimado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">en 10 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ETEV secundaria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Episodio grave de EP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">30&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ETEV idiop&#225;tica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1477606.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Los pacientes con un segundo episodio de ETEV tienen un riesgo de recurrencia de aproximadamente un 50&#37; mayor que los que tienen un episodio&#46;</p> <p class="elsevierStyleNotepara" id="npar0010">EP&#58; embolia pulmonar&#59; ETEV&#58; enfermedad tromboemb&#243;lica venosa&#59; TVP&#58; trombosis venosa profunda&#59;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Riesgo de recurrencia estimado de enfermedad tromboemb&#243;lica venosa</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabla 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Tratamiento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Duraci&#243;n tratamiento &#40;meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hemorragia mayor &#40;eventos&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Riesgo recurrencia frente a placebo HR &#40;IC 95&#37;&#41;&#59; p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Riesgo hemorragia cl&#237;nicamente relevante<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a> frente a placebo HR &#40;IC 95&#37;&#41;&#59; p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">PADIS<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">AVK&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">18&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;15<br>&#40;0&#44;51-0&#44;90&#41; p<span class="elsevierStyleHsp" style=""></span>&#8804;<span class="elsevierStyleHsp" style=""></span>0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&#44;96<br>&#40;0&#44;19-9&#44;35&#41; p <span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;22&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">RE-SONATE<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Dabigatr&#225;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;08<br>&#40;0&#44;02-0&#44;25&#41; p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;01&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;92<br>&#40;1&#44;52-5&#44;60&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">EINSTEIN-EXT<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Rivaroxab&#225;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;18<br>&#40;0&#44;09-0&#44;39&#41; p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&#44;19<br>&#40;2&#44;13-11&#44;7&#41; p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">AMPLIFY-EXT<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Apixab&#225;n &#40;2&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;19<br>&#40;0&#44;11-0&#44;33&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;20<br>&#40;0&#44;69-2&#44;10&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">AMPLIFY-EXT<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Apixab&#225;n &#40;5<span class="elsevierStyleHsp" style=""></span>mg&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;20<br>&#40;0&#44;11-0&#44;34&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;62<br>&#40;0&#44;96-2&#44;73&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ASPIRE-WARFASA<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#193;cido acetilsalic&#237;lico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24 &#40;48&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;68<br>&#40;0&#44;51-0&#44;90&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;50<br>&#40;0&#44;72-3&#44;14&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;28&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SURVET<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sulodexida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;45<br>&#40;0&#44;27-0&#44;92&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;02&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;97<br>&#40;0&#44;14-6&#44;88&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;98&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1477607.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Mayor o no mayor cl&#237;nicamente relevante&#46;</p> <p class="elsevierStyleNotepara" id="npar0020">p nd&#58; valor de probabilidad no disponible en el art&#237;culo original&#46;</p> <p class="elsevierStyleNotepara" id="npar0025">AVK&#58; antivitamina K&#59; HR&#58; <span class="elsevierStyleItalic">Hazard Ratio</span>&#59; IC-95&#37;&#58; intervalo de confianza al 95&#37;&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Estudios en prevenci&#243;n de recurrencia de enfermedad tromboemb&#243;lica venosa</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Tabla 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">ACOD vs AVK&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">N&#250;mero de pacientes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Mortalidad global&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Recurrencia<br>&#40;IC-95&#37;&#41;p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hemorragia mayor<br>&#40;IC-95&#37;&#41;p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hemorragia cl&#237;nicamente relevante<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">&#42;</span></a><br>&#40;IC-95&#37;&#41;p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hemorragia<br>intracraneal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dabigatran<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a><br>RE-MEDY&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#46;856&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;89<br>&#40;0&#44;47-1&#44;71&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;44<br>&#40;0&#44;79-2&#46;62&#41; p 0&#44;01&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;52<br>&#40;0&#44;27-1&#44;01&#41; p 0&#44;06&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;54<br>&#40;0&#44;41-0&#44;71&#41; p&#60;0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Eventos 2 vs&#46; 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Edoxaban<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a><br>HOKUSAI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&#46;118&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;97<br>&#40;0&#44;69-1&#44;38&#41;<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">&#42;&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;45<br>&#40;0&#44;22-0&#44;92&#41;<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">&#42;&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;97<br>&#40;0&#44;77-1&#44;22&#41;<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">&#42;&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;16<br>&#40;0&#44;02-1&#44;36&#41;<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">&#42;&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1477608.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Mayor o no mayor cl&#237;nicamente relevante&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0020"
              "etiqueta" => "&#42;&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0035">La significaci&#243;n estad&#237;stica &#40;valor de p&#41; no est&#225; disponible en el art&#237;culo original&#46;</p> <p class="elsevierStyleNotepara" id="npar0040">ACOD&#58; anticoagulantes orales de acci&#243;n directa&#59; AVK&#58; antivitamina K&#59; HR&#58; <span class="elsevierStyleItalic">Hazard Ratio</span>&#59; IC-95&#37;&#58; intervalo de confianza al 95&#37;&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Anticoagulantes orales de acci&#243;n directa frente a antivitamina K en el tratamiento extendido de la enfermedad tromboemb&#243;lica venosa</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:38 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46; Pengo"
                            1 => "A&#46;W&#46; Lensing"
                            2 => "M&#46;H&#46; Prins"
                            3 => "A&#46; Marchiori"
                            4 => "B&#46;L&#46; Davidson"
                            5 => "F&#46; Tiozzo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa032274"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2004"
                        "volumen" => "350"
                        "paginaInicial" => "2257"
                        "paginaFinal" => "2264"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15163775"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The long-term clinical course of acute deep venous thrombosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Prandoni"
                            1 => "A&#46;W&#46; Lensing"
                            2 => "A&#46; Congo"
                            3 => "S&#46; Cuppini"
                            4 => "S&#46; Villalta"
                            5 => "M&#46; Carta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Intern Med&#46;"
                        "fecha" => "1996"
                        "volumen" => "125"
                        "paginaInicial" => "1"
                        "paginaFinal" => "7"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8644983"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor&#58; a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Iorio"
                            1 => "C&#46; Kearon"
                            2 => "E&#46; Filippucci"
                            3 => "M&#46; Marcucci"
                            4 => "A&#46; Macura"
                            5 => "V&#46; Pengo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archinternmed.2010.367"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med&#46;"
                        "fecha" => "2010"
                        "volumen" => "170"
                        "paginaInicial" => "1710"
                        "paginaFinal" => "1716"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20975016"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism&#46; A prospective cohort study in 1&#44;626 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Prandoni"
                            1 => "F&#46; Noventa"
                            2 => "A&#46; Ghirarduzzi"
                            3 => "V&#46; Pengo"
                            4 => "E&#46; Bernardi"
                            5 => "R&#46; Pesavento"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Haematologica"
                        "fecha" => "2007"
                        "volumen" => "92"
                        "paginaInicial" => "199"
                        "paginaFinal" => "205"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17296569"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;D&#46; Douketis"
                            1 => "C&#46;S&#46; Gu"
                            2 => "S&#46; Schulman"
                            3 => "A&#46; Ghirarduzzi"
                            4 => "V&#46; Pengo"
                            5 => "P&#46; Prandoni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Intern Med&#46;"
                        "fecha" => "2007"
                        "volumen" => "147"
                        "paginaInicial" => "766"
                        "paginaFinal" => "774"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18056660"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antithrombotic therapy for VTE disease&#58; CHEST guideline and expert panel report"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kearon"
                            1 => "E&#46;A&#46; Akl"
                            2 => "J&#46; Ornelas"
                            3 => "A&#46; Blaivas"
                            4 => "D&#46; Jimenez"
                            5 => "H&#46; Bounameaux"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.chest.2015.11.026"
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest"
                        "fecha" => "2016"
                        "volumen" => "149"
                        "paginaInicial" => "315"
                        "paginaFinal" => "352"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26867832"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology &#40;ESC&#41;&#46; 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;V&#46; Konstantinides"
                            1 => "A&#46; Torbicki"
                            2 => "G&#46; Agnelli"
                            3 => "N&#46; Danchin"
                            4 => "D&#46; Fitzmaurice"
                            5 => "N&#46; Galie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehu283"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Heart J&#46;"
                        "fecha" => "2014"
                        "volumen" => "35"
                        "paginaInicial" => "3033"
                        "paginaFinal" => "3069"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25173341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Kearon"
                            1 => "E&#46;A&#46; Akl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2013-12-512681"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2014"
                        "volumen" => "123"
                        "paginaInicial" => "1794"
                        "paginaFinal" => "1801"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24497538"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment&#58; analysis of individual participants&#8217; data from seven trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Boutitie"
                            1 => "L&#46; Pinede"
                            2 => "S&#46; Schulman"
                            3 => "G&#46; Agnelli"
                            4 => "G&#46; Raskob"
                            5 => "J&#46; Julian"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ&#46;"
                        "fecha" => "2011"
                        "volumen" => "342"
                        "paginaInicial" => "d3036"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21610040"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "PROLONG Investigators&#46; D-dimer testing to determine the duration of anticoagulation therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Palareti"
                            1 => "B&#46; Cosmi"
                            2 => "C&#46; Legnani"
                            3 => "A&#46; Tosetto"
                            4 => "C&#46; Brusi"
                            5 => "A&#46; Iorio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa054444"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2006"
                        "volumen" => "355"
                        "paginaInicial" => "1780"
                        "paginaFinal" => "1789"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17065639"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism&#58; the PROLONG II prospective study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "B&#46; Cosmi"
                            1 => "C&#46; Legnani"
                            2 => "A&#46; Tosetto"
                            3 => "V&#46; Pengo"
                            4 => "A&#46; Ghirarduzzi"
                            5 => "S&#46; Testa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2009-08-237354"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2010"
                        "volumen" => "115"
                        "paginaInicial" => "481"
                        "paginaFinal" => "488"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19965693"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis&#58; the duration of anticoagulation based on compression ultrasonography &#40;DACUS&#41; study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "S&#46; Siragusa"
                            1 => "A&#46; Malato"
                            2 => "R&#46; Anastasio"
                            3 => "V&#46; Cigna"
                            4 => "G&#46; Milio"
                            5 => "C&#46; Amato"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2008-01-131656"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2008"
                        "volumen" => "112"
                        "paginaInicial" => "511"
                        "paginaFinal" => "515"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18497320"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism&#58; a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "D&#46; Garcia"
                            1 => "E&#46;A&#46; Akl"
                            2 => "R&#46; Carr"
                            3 => "C&#46; Kearon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2013-04-496257"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2013"
                        "volumen" => "122"
                        "paginaInicial" => "817"
                        "paginaFinal" => "824"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23760616"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence&#63;&#46; A patient-level meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "T&#46; Baglin"
                            1 => "J&#46; Douketis"
                            2 => "A&#46; Tosetto"
                            3 => "M&#46; Marcucci"
                            4 => "M&#46; Cushman"
                            5 => "P&#46; Kyrle"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2010"
                        "volumen" => "8"
                        "paginaInicial" => "2436"
                        "paginaFinal" => "2442"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46;A&#46; Rodger"
                            1 => "S&#46;R&#46; Kahn"
                            2 => "P&#46;S&#46; Wells"
                            3 => "D&#46;A&#46; Anderson"
                            4 => "I&#46; Chagnon"
                            5 => "G&#46; Le Gal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1503/cmaj.080493"
                      "Revista" => array:6 [
                        "tituloSerie" => "CMAJ&#46;"
                        "fecha" => "2008"
                        "volumen" => "179"
                        "paginaInicial" => "417"
                        "paginaFinal" => "426"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18725614"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Predicting disease recurrence in patients with previous unprovoked venous thromboembolism&#46; A proposed prediction score &#40;DASH&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Tosetto"
                            1 => "A&#46; Iorio"
                            2 => "M&#46; Marcucci"
                            3 => "T&#46; Baglin"
                            4 => "M&#46; Cushman"
                            5 => "S&#46; Eichinger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2012"
                        "volumen" => "10"
                        "paginaInicial" => "1019"
                        "paginaFinal" => "1025"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism&#58; the Vienna prediction model"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "S&#46; Eichinger"
                            1 => "G&#46; Heinze"
                            2 => "L&#46;M&#46; Jandeck"
                            3 => "P&#46;A&#46; Kyrle"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.109.925214"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2010"
                        "volumen" => "121"
                        "paginaInicial" => "1630"
                        "paginaFinal" => "1636"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20351233"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "C&#46; Kearon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2009"
                        "volumen" => "7"
                        "numero" => "Suppl&#46; 1"
                        "paginaInicial" => "296"
                        "paginaFinal" => "300"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical impact of bleeding in patients taking oral anticoagulation for venous thromboembolism&#46; A meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46;A&#46; Linkis"
                            1 => "P&#46;T&#46; Choi"
                            2 => "D&#46; Duketis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Ann Inter Med&#46;"
                        "fecha" => "2003"
                        "volumen" => "139"
                        "paginaInicial" => "893"
                        "paginaFinal" => "900"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical outcome of patients with major bleeding after venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Nieto"
                            1 => "T&#46; C&#225;mara"
                            2 => "E&#46; Gonz&#225;lez-Higueras"
                            3 => "N&#46; Ruiz Jim&#233;nez"
                            4 => "R&#46; Guijarro"
                            5 => "P&#46;J&#46; Marchena"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "ThrombHaemost&#46;"
                        "fecha" => "2008"
                        "volumen" => "100"
                        "paginaInicial" => "789"
                        "paginaFinal" => "796"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Three months versus one year of oral anticoagulant therapy for idiopathic deep vein thrombosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "AgnelliG"
                            1 => "P&#46; Prandoni"
                            2 => "M&#46;G&#46; Santamaria"
                            3 => "P&#46; Bagatella"
                            4 => "A&#46; Iorio"
                            5 => "M&#46; Bazzan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Eng J Med&#46;"
                        "fecha" => "2001"
                        "volumen" => "345"
                        "paginaInicial" => "165"
                        "paginaFinal" => "169"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kearon"
                            1 => "M&#46; Gent"
                            2 => "J&#46; Hirsh"
                            3 => "J&#46; Weitz"
                            4 => "M&#46;J&#46; Kovacs"
                            5 => "D&#46;R&#46; Anderson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM199903253401201"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "1999"
                        "volumen" => "340"
                        "paginaInicial" => "901"
                        "paginaFinal" => "907"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10089183"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "For the PREVENT investigators&#46; Long-term&#44; low-intensity warfarin therapy for prevention of recurrent venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46;M&#46; Ridker"
                            1 => "S&#46;Z&#46; Goldhaber"
                            2 => "E&#46; Danielson"
                            3 => "Y&#46; Rosenberg"
                            4 => "C&#46;S&#46; Eby"
                            5 => "S&#46;R&#46; Deitcher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Eng J Med"
                        "fecha" => "2003"
                        "volumen" => "348"
                        "paginaInicial" => "1425"
                        "paginaFinal" => "1434"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Duration of anticoagulation following venous thromboembolism&#58; a meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "D&#46; Ost"
                            1 => "J&#46; Tepper"
                            2 => "H&#46; Mihara"
                            3 => "O&#46; Lander"
                            4 => "R&#46; Heinzer"
                            5 => "A&#46; Fein"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.294.6.706"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2005"
                        "volumen" => "294"
                        "paginaInicial" => "706"
                        "paginaFinal" => "715"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16091573"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Post-thrombotic syndrome&#44; recurrence&#44; and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Schulman"
                            1 => "P&#46; Lindmarker"
                            2 => "M&#46; Holmstrom"
                            3 => "G&#46; Larfars"
                            4 => "A&#46; Carlsson"
                            5 => "P&#46; Nicol"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2006"
                        "volumen" => "4"
                        "paginaInicial" => "734"
                        "paginaFinal" => "742"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kearon"
                            1 => "J&#46;S&#46; Ginsberg"
                            2 => "M&#46;J&#46; Kovacs"
                            3 => "D&#46;R&#46; Anderson"
                            4 => "P&#46;S&#46; Wells"
                            5 => "J&#46;A&#46; Julian"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa035422"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2003"
                        "volumen" => "349"
                        "paginaInicial" => "631"
                        "paginaFinal" => "639"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12917299"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of outcomes after hospitalization for deep vein thrombosis or pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; Murin"
                            1 => "P&#46;S&#46; Romano"
                            2 => "R&#46;H&#46; White"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "ThrombHaemost&#46;"
                        "fecha" => "2002"
                        "volumen" => "88"
                        "paginaInicial" => "407"
                        "paginaFinal" => "414"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Quality of INR control and outcomes following venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46;M&#46; Gallagher"
                            1 => "F&#46; Vries"
                            2 => "J&#46;M&#46; Plumb"
                            3 => "B&#46; Ha&#223;"
                            4 => "A&#46; Clemens"
                            5 => "T&#46;P&#46; van Staa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "ClinApplThrombHemost&#46;"
                        "fecha" => "2012"
                        "volumen" => "18"
                        "paginaInicial" => "370"
                        "paginaFinal" => "378"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Six months vs extended oral anticoagulation after a first episode of pulmonary embolism&#58; The PADIS-PE randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PADIS-PE Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Couturaud"
                            1 => "O&#46; Sanchez"
                            2 => "G&#46; Pernod"
                            3 => "P&#46; Mismetti"
                            4 => "P&#46; Jego"
                            5 => "E&#46; Duhamel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2015.7046"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2015"
                        "volumen" => "314"
                        "paginaInicial" => "31"
                        "paginaFinal" => "40"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26151264"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "RE-SONATE trial investigators&#46; Extended use of dabigatran&#44; warfarin&#44; or placebo in venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "RE-MEDY trial investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Schulman"
                            1 => "C&#46; Kearon"
                            2 => "A&#46;K&#46; Kakkar"
                            3 => "S&#46; Schellong"
                            4 => "H&#46; Eriksson"
                            5 => "D&#46; Baanstra"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1113697"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2013"
                        "volumen" => "368"
                        "paginaInicial" => "709"
                        "paginaFinal" => "718"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23425163"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Oral rivaroxaban after symptomatic venous thromboembolism&#58; the continued treatment study &#40;EINSTEIN-extension study&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "E&#46; Romualdi"
                            1 => "M&#46;P&#46; Donadini"
                            2 => "W&#46; Agerno"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Expert Rev CardiovascTher&#46;"
                        "fecha" => "2011"
                        "volumen" => "9"
                        "paginaInicial" => "841"
                        "paginaFinal" => "844"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Apixaban for extended treatment of venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "for the AMPLIFY-EXT Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Agnelli"
                            1 => "H&#46;R&#46; Buller"
                            2 => "A&#46; Cohen"
                            3 => "M&#46; Curto"
                            4 => "A&#46;S&#46; Gallus"
                            5 => "M&#46; Johnson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/ NEJMoa1207541"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2013"
                        "volumen" => "368"
                        "paginaInicial" => "699"
                        "paginaFinal" => "708"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23216615"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis&#58; a systematic review and meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46; Carrier"
                            1 => "C&#46; Cameron"
                            2 => "A&#46; Delluc"
                            3 => "L&#46; Castellucci"
                            4 => "A&#46;A&#46; Khorana"
                            5 => "A&#46;Y&#46; Lee"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.thromres.2014.09.039"
                      "Revista" => array:6 [
                        "tituloSerie" => "Thromb Res&#46;"
                        "fecha" => "2014"
                        "volumen" => "134"
                        "paginaInicial" => "1214"
                        "paginaFinal" => "1219"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25457583"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer&#58; a randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;Y&#46; Lee"
                            1 => "P&#46;W&#46; Kamphuisen"
                            2 => "G&#46; Meyer"
                            3 => "R&#46; Bauersachs"
                            4 => "M&#46;S&#46; Janas"
                            5 => "M&#46;F&#46; Jarner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2015.9243"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2015"
                        "volumen" => "314"
                        "paginaInicial" => "677"
                        "paginaFinal" => "686"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26284719"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiology and management of bleeding in patients using vitamin K antagonists"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46; Levi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2009"
                        "volumen" => "7"
                        "numero" => "Suppl&#46;1"
                        "paginaInicial" => "103"
                        "paginaFinal" => "106"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism&#58; A post- hoc analysis of the Hokusai-VTE study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Raskob"
                            1 => "W&#46; Ageno"
                            2 => "A&#46;T&#46; Cohen"
                            3 => "M&#46;P&#46; Brekelmans"
                            4 => "M&#46;A&#46; Grosso"
                            5 => "A&#46; Segers"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Lancet Haematol&#46;"
                        "fecha" => "2016"
                        "volumen" => "3"
                        "paginaInicial" => "228"
                        "paginaFinal" => "236"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Aspirin for the prevention of recurrent venous thromboembolism&#58; the INSPIRE collaboration"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "INSPIRE Study Investigators &#40;International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism&#41;"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Simes"
                            1 => "C&#46; Becattini"
                            2 => "G&#46; Agnelli"
                            3 => "J&#46;W&#46; Eikelboom"
                            4 => "A&#46;C&#46; Kirby"
                            5 => "R&#46; Mister"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.114.008828"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2014"
                        "volumen" => "130"
                        "paginaInicial" => "1062"
                        "paginaFinal" => "1071"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25156992"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The sulodexide in secondary prevention of recurrent deep vein thrombosis &#40;SURVET&#41; study&#58; A multicenter&#44; randomized&#44; double blind&#44; placebo- controlled trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "on belhaf of the SURVET Study investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46;M&#46; Andreozzi"
                            1 => "A&#46;A&#46; Bignamini"
                            2 => "G&#46; Davi"
                            3 => "G&#46; Palareti"
                            4 => "J&#46; Matuska"
                            5 => "M&#46; Holy"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.115.016930"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2015"
                        "volumen" => "132"
                        "paginaInicial" => "1891"
                        "paginaFinal" => "1897"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26408273"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00142565/0000021700000006/v1_201707280054/S0014256517300978/v1_201707280054/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66382"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Pros y Contras"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00142565/0000021700000006/v1_201707280054/S0014256517300978/v1_201707280054/es/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256517300978?idApp=WRCEE"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Pros y Contras
Anticoagulación extendida en la enfermedad tromboembólica venosa. A favor
Extended anticoagulation in venous thromboembolism disease. In favour
M.C. Fernández Capitan
Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, España
Leído
143
Veces
se ha leído el artículo
62
Total PDF
81
Total HTML
Compartir estadísticas
 array:23 [
  "pii" => "S0014256517300978"
  "issn" => "00142565"
  "doi" => "10.1016/j.rce.2017.02.017"
  "estado" => "S300"
  "fechaPublicacion" => "2017-08-01"
  "aid" => "1386"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "fla"
  "cita" => "Rev Clin Esp. 2017;217:359-64"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 130
    "formatos" => array:2 [
      "HTML" => 79
      "PDF" => 51
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S225488741730053X"
      "issn" => "22548874"
      "doi" => "10.1016/j.rceng.2017.04.003"
      "estado" => "S300"
      "fechaPublicacion" => "2017-08-01"
      "aid" => "1386"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Medicina Interna &#40;SEMI&#41;"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "fla"
      "cita" => "Rev Clin Esp. 2017;217:359-64"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 2
        "PDF" => 2
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">For and against</span>"
        "titulo" => "Extended anticoagulation in venous thromboembolism disease&#46; In favor"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "es"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "359"
            "paginaFinal" => "364"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Anticoagulaci&#243;n extendida en la enfermedad tromboemb&#243;lica venosa&#46; A favor"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "M&#46;C&#46; Fern&#225;ndez"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "M&#46;C&#46;"
                "apellidos" => "Fern&#225;ndez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0014256517300978"
          "doi" => "10.1016/j.rce.2017.02.017"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256517300978?idApp=WRCEE"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S225488741730053X?idApp=WRCEE"
      "url" => "/22548874/0000021700000006/v1_201707280038/S225488741730053X/v1_201707280038/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0014256517300759"
    "issn" => "00142565"
    "doi" => "10.1016/j.rce.2017.02.012"
    "estado" => "S300"
    "fechaPublicacion" => "2017-08-01"
    "aid" => "1380"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Medicina Interna &#40;SEMI&#41;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Rev Clin Esp. 2017;217:365-9"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 148
      "formatos" => array:2 [
        "HTML" => 88
        "PDF" => 60
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">PROS Y CONTRAS</span>"
      "titulo" => "Duraci&#243;n del tratamiento anticoagulante&#46; A favor de plazos cortos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "365"
          "paginaFinal" => "369"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Anticoagulant therapy duration&#46; In favour of short-term courses"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1837
              "Ancho" => 2344
              "Tamanyo" => 125585
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Acontecimientos adversos durante el seguimiento en pacientes con enfermedad tromoboemb&#243;lica venosa&#44; tratados&#46; Incidencia de fallecimientos por embolia pulmonar &#40;l&#237;neas negras&#41; y hemorragia &#40;l&#237;neas claras&#41; en 53&#46;222 pacientes diagnosticados de embolia pulmonar y trombosis venosa profunda&#44; a partir del tercer mes despu&#233;s del diagn&#243;stico&#46;</p> <p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Las muertes por hemorragia en todo momento superan a las de embolia pulmonar&#46; Para una comparaci&#243;n m&#225;s ajustada&#44; al n&#250;mero de fallecimientos por hemorragia hay que restar 0&#44;14&#37; &#40;0&#44;06-0&#44;26&#37;&#41; de fallecimientos anuales que ocurrir&#237;an si estos pacientes no estuvieran anticoagulados&#46;</p> <p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">EP&#58; embolia pulmonar&#59; TVP&#58; trombosis venosa profunda&#46;</p> <p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Fuente&#58; registro RIETE &#40;datos no publicados&#41; y Castellucci et al&#46;<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">21</span></a>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46;A&#46; Nieto Rodr&#237;guez, J&#46;C&#46; Ram&#237;rez Luna"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "J&#46;A&#46;"
              "apellidos" => "Nieto Rodr&#237;guez"
            ]
            1 => array:2 [
              "nombre" => "J&#46;C&#46;"
              "apellidos" => "Ram&#237;rez Luna"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2254887417300401"
        "doi" => "10.1016/j.rceng.2017.04.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887417300401?idApp=WRCEE"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256517300759?idApp=WRCEE"
    "url" => "/00142565/0000021700000006/v1_201707280054/S0014256517300759/v1_201707280054/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0014256517301017"
    "issn" => "00142565"
    "doi" => "10.1016/j.rce.2017.03.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-08-01"
    "aid" => "1390"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Medicina Interna &#40;SEMI&#41;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "ssu"
    "cita" => "Rev Clin Esp. 2017;217:351-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 260
      "formatos" => array:2 [
        "HTML" => 154
        "PDF" => 106
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Simposio&#46; Pluripatolog&#237;a</span>"
      "titulo" => "Modelos de atenci&#243;n al paciente pluripatol&#243;gico"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "351"
          "paginaFinal" => "358"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Care models for polypathological patients"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1120
              "Ancho" => 2498
              "Tamanyo" => 168493
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">El modelo de cuidados de pacientes con enfermedades cr&#243;nicas&#46;</p> <p id="spar0020" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Fuente&#58; Cuidados innovadores para las condiciones cr&#243;nicas&#58; organizaci&#243;n y prestaci&#243;n de atenci&#243;n de alta calidad a las enfermedades cr&#243;nicas no transmisibles en las Am&#233;ricas</span>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "A&#46; Fern&#225;ndez Moyano, J&#46;M&#46; Mach&#237;n L&#225;zaro, M&#46;D&#46; Mart&#237;n Escalante, M&#46;B&#46; Aller Hernandez, I&#46; Vallejo Maroto"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Fern&#225;ndez Moyano"
            ]
            1 => array:2 [
              "nombre" => "J&#46;M&#46;"
              "apellidos" => "Mach&#237;n L&#225;zaro"
            ]
            2 => array:2 [
              "nombre" => "M&#46;D&#46;"
              "apellidos" => "Mart&#237;n Escalante"
            ]
            3 => array:2 [
              "nombre" => "M&#46;B&#46;"
              "apellidos" => "Aller Hernandez"
            ]
            4 => array:2 [
              "nombre" => "I&#46;"
              "apellidos" => "Vallejo Maroto"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S225488741730067X"
        "doi" => "10.1016/j.rceng.2017.05.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S225488741730067X?idApp=WRCEE"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256517301017?idApp=WRCEE"
    "url" => "/00142565/0000021700000006/v1_201707280054/S0014256517301017/v1_201707280054/es/main.assets"
  ]
  "es" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Pros y Contras</span>"
    "titulo" => "Anticoagulaci&#243;n extendida en la enfermedad tromboemb&#243;lica venosa&#46; A favor"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "359"
        "paginaFinal" => "364"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "M&#46;C&#46; Fern&#225;ndez Capitan"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "M&#46;C&#46;"
            "apellidos" => "Fern&#225;ndez Capitan"
            "email" => array:1 [
              0 => "mfcapitan&#64;salud&#46;madrid&#46;org"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Medicina Interna&#44; Hospital Universitario La Paz&#44; Madrid&#44; Espa&#241;a"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Extended anticoagulation in venous thromboembolism disease&#46; In favour"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">La enfermedad tromboemb&#243;lica venosa &#40;ETEV&#41; es una enfermedad grave que&#44; a pesar de los avances diagn&#243;sticos y terap&#233;uticos&#44; mantiene una mortalidad elevada &#40;13&#37;&#41; y produce secuelas importantes como la hipertensi&#243;n pulmonar &#40;3&#37; anual&#41;&#44; o el s&#237;ndrome postromb&#243;tico &#40;SPT&#41; &#40;30&#37; en 8 a&#241;os&#41;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;2</span></a>&#46; La ETEV puede considerarse una enfermedad cr&#243;nica ya que&#44; despu&#233;s de un primer episodio&#44; el riesgo anual de recurrencia es del 2-3&#44;8&#37;&#44; alcanzando el 30-50&#37; en 10 a&#241;os&#44; con una mortalidad asociada del 3-18&#37;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3-5</span></a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Las gu&#237;as de pr&#225;ctica cl&#237;nica<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6&#44;7</span></a> recomiendan realizar tratamiento anticoagulante de duraci&#243;n limitada en la mayor&#237;a de pacientes con ETEV&#44; pero el alto riesgo de recurrencia hace que muchos requieran su prolongaci&#243;n<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a>&#46; Aunque la anticoagulaci&#243;n prolongada es eficaz&#44; el riesgo de recurrencia permanece cuando se retira y se desconoce cu&#225;l debe ser la duraci&#243;n &#243;ptima del tratamiento<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a>&#46; Por lo tanto&#44; la decisi&#243;n m&#225;s dif&#237;cil en la ETEV no es la de anticoagular&#44; ni a qui&#233;n&#44; o qu&#233; tratamiento utilizar&#44; sino cu&#225;ndo suspender los anticoagulantes a un paciente despu&#233;s de un tiempo limitado de tratamiento&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">En la gu&#237;a del <span class="elsevierStyleItalic">American College of Chest Physicians</span> &#40;ACCP&#41;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> se sugiere&#44; como duraci&#243;n m&#225;s adecuada de tratamiento con diferentes grados de recomendaci&#243;n basados en la evidencia&#44; 3 meses en los pacientes con ETEV &#171;provocada&#187;&#46; Asimismo&#44; se recomienda prolongar la anticoagulaci&#243;n&#44; sin fecha programada de finalizaci&#243;n &#40;&#171;anticoagulaci&#243;n extendida&#187;&#41;&#44; en aquellos pacientes con ETEV idiop&#225;tica de repetici&#243;n o asociada a c&#225;ncer&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">La duda fundamental para extender la anticoagulaci&#243;n surge en los pacientes que han sufrido un primer episodio de ETEV no provocada&#44; sobre todo en aquellos sin riesgo elevado de sangrado<span class="elsevierStyleBold">&#46;</span> No existe una regla de predicci&#243;n cl&#237;nica que clasifique a estos pacientes y la decisi&#243;n&#44; siempre dif&#237;cil&#44; se basa en una cuidadosa valoraci&#243;n del riesgo y el beneficio de la anticoagulaci&#243;n&#59; beneficio de evitar una recurrencia y sus consecuencias&#44; y riesgo de hemorragia&#44; sobre todo la temida hemorragia intracraneal&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">La decisi&#243;n de mantener la anticoagulaci&#243;n debe fundarse principalmente en el riesgo de recurrencia&#44; ya que el riesgo de hemorragia es secundario&#44; dif&#237;cil de predecir y debe asumirse cuando el primero es elevado&#46; En cualquier caso&#44; antes de tomar una decisi&#243;n definitiva es necesario facilitar una informaci&#243;n clara y compresible al paciente y tener en cuenta su opini&#243;n&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Riesgo de recurrencia y de hemorragia</span><p id="par0030" class="elsevierStylePara elsevierViewall">El riesgo de recurrencia se mantiene a lo largo de toda la vida del paciente y&#44; aunque es mayor en el caso de ETEV idiop&#225;tica&#44; tambi&#233;n existe cuando hay factores de riesgo &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#46; Para facilitar la decisi&#243;n terap&#233;utica se han buscado factores que puedan ayudar a estratificar el riesgo de recurrencia&#44; como el g&#233;nero del paciente y la concentraci&#243;n de d&#237;mero D medido un mes despu&#233;s de suspender la anticoagulaci&#243;n&#46; Los hombres tienen un riesgo de recidiva 1&#44;75 veces mayor que las mujeres&#44; y los pacientes con d&#237;mero D elevado el doble que los que lo tienen normal<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9-11</span></a>&#46; Tambi&#233;n se han utilizado otros factores como la edad &#40;&#60;<span class="elsevierStyleHsp" style=""></span>50 a&#241;os&#41;&#44; la persistencia de trombosis venosa &#40;&#62;<span class="elsevierStyleHsp" style=""></span>40&#37; de la luz obstruida&#44; riesgo relativo &#91;RR&#93; 1&#44;5&#41;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a>&#44; la trombofilia &#40;RR&#58; 1&#44;5&#59; s&#237;ndrome antifosfol&#237;pido RR&#58; 2&#41;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> o el SPT&#46; Por &#250;ltimo&#44; es importante considerar la forma de expresi&#243;n cl&#237;nica inicial de la ETEV&#46; Los pacientes con trombosis venosa profunda &#40;TVP&#41; distal tienen un riesgo de recurrencia 5 veces menor que aquellos con TVP proximal y&#44; por otra parte&#44; en los pacientes con embolia pulmonar &#40;EP&#41; el riesgo de que la recurrencia se manifieste como un nuevo episodio de EP se multiplica por 3&#44; con el consiguiente aumento de mortalidad<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14&#44;15</span></a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">Muchos de estos factores se han recogido en escalas de predicci&#243;n de la recidiva<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11-16&#44;17</span></a>&#46; Un riesgo de recurrencia menor del 5&#37; al a&#241;o o del 15&#37; a los 5 a&#241;os se considera aceptable y justificar&#237;a suspender la anticoagulaci&#243;n despu&#233;s de 3 meses de tratamiento&#46; Sin embargo&#44; la falta de validaci&#243;n de estos factores hace que no existan recomendaciones firmes sobre su utilizaci&#243;n para decidir el tiempo de anticoagulaci&#243;n tras una primera ETEV idiop&#225;tica<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a>&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Tambi&#233;n existen escalas para estimar el riesgo de hemorragia&#44; inherente al tratamiento anticoagulante&#44; en funci&#243;n de la existencia de diversos factores&#46; Nuevamente&#44; el hecho de estar basadas en estudios realizados en pacientes anticoagulados por otras causas o en pacientes con ETEV durante un tratamiento de duraci&#243;n prefijada&#44; limita su utilidad en la valoraci&#243;n de extender la anticoagulaci&#243;n&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Balance del riesgo-beneficio de extender la anticoagulaci&#243;n</span><p id="par0045" class="elsevierStylePara elsevierViewall">La consecuencia m&#225;s grave de una recurrencia o de una hemorragia es la muerte del paciente&#46; La tasa global de mortalidad por ETEV recurrente es del 3&#44;6&#37; &#40;1&#44;9-5&#44;7&#37;&#41;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3-5</span></a>&#46; La tasa de mortalidad por hemorragia var&#237;a a lo largo del tiempo&#46; Seg&#250;n un metaan&#225;lisis&#44; en los 3 primeros meses de anticoagulaci&#243;n la tasa de hemorragia mayor es del 2&#44;06&#37; &#40;2&#44;04-2&#44;08&#37;&#41; y la de hemorragia mortal es del 0&#44;37&#37; &#40;0&#44;36-0&#44;38&#37;&#41;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a>&#44; similar a lo observado en pacientes del &#171;Registro Informatizado de pacientes con Enfermedad TromboEmb&#243;lica&#187; &#40;RIETE&#41;&#44; con cifras respectivas del 2&#44;2 y 0&#44;56&#37;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a>&#46; Despu&#233;s de 3 meses estas tasas son del 2&#44;74 y 0&#44;63&#37;&#44; respectivamente<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a>&#46; Muchos de estos datos proceden de estudios retrospectivos y ensayos cl&#237;nicos realizados en pacientes seleccionados o que reciben anticoagulaci&#243;n durante un tiempo limitado&#44; por lo que infraestiman la incidencia real de recurrencia&#44; y su validez para decidir la prolongaci&#243;n o no del tratamiento es cuestionable<span class="elsevierStyleItalic">&#46;</span> Adem&#225;s&#44; es importante considerar que las recurrencias no mortales tambi&#233;n son importantes&#44; ya que pueden producir un SPT y un deterioro cr&#243;nico y progresivo de la situaci&#243;n cardiopulmonar del paciente&#44; con el consiguiente coste emocional&#44; social y econ&#243;mico&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Los estudios realizados<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5&#44;21</span></a> para comparar diferentes duraciones de tratamiento en pacientes con un primer episodio de ETEV que hab&#237;an completado 6 meses de tratamiento demostraron que los f&#225;rmacos antivitamina K &#40;AVK&#41;&#44; con un objetivo terap&#233;utico seg&#250;n una raz&#243;n internacional normalizada &#40;INR&#41; de 2&#44;5 &#40;entre 2 y 3&#41;&#44; fueron muy eficaces para prevenir nuevos eventos tromb&#243;ticos&#46; Sin embargo&#44; tras suspender la anticoagulaci&#243;n&#44; el riesgo de recurrencias fue igual para los tratados durante 6 o 24 meses<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a>&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Los estudios<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10&#44;22&#44;23</span></a> que compararon la prolongaci&#243;n de la anticoagulaci&#243;n con AVK durante m&#225;s de 3 meses con la suspensi&#243;n del tratamiento en los pacientes con ETEV idiop&#225;tica han demostrado que la anticoagulaci&#243;n a largo plazo reduce las recurrencias en un 90&#37;&#46; Al igual que en otros estudios&#44; estas fueron elevadas en los pacientes sin tratamiento extendido&#44; estim&#225;ndose en un 10&#37; el primer a&#241;o&#44; un 30&#37; a los 5 a&#241;os y hasta un 50&#37; a los 10 a&#241;os<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2&#44;22-25</span></a>&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">El riesgo de hemorragia mayor aument&#243; durante la anticoagulaci&#243;n extendida &#40;1-2&#37; al a&#241;o&#44; RR&#58; 1&#44;8&#59; intervalo de confianza &#91;IC&#93; del 95&#37;&#58; 0&#44;7-4&#44;5&#41;<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#44; siendo solo la mitad de los sangrados atribuibles al tratamiento<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#46; La frecuencia acumulada de la variable compuesta &#171;ETEV recurrente y hemorragia mayor&#187; fue mucho menor en los pacientes que permanecieron anticoagulados<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;23-26</span></a>&#44; y el beneficio&#44; mayor cuanto m&#225;s prolongado el seguimiento<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Alrededor del 10&#37; de las hemorragias mayores durante el tratamiento extendido son mortales<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a>&#44; mientras que la mortalidad por recurrencia es aproximadamente del 5&#37; en el caso de la TVP y del 15-18&#37; en la EP<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5&#44;25&#44;27</span></a>&#46; Sin embargo&#44; aunque la mortalidad por hemorragias puede ser mayor que la debida a recurrencias&#44; el gran n&#250;mero de recurrencias supera las consecuencias del aumento de hemorragias si se prolonga la anticoagulaci&#243;n&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Por otra parte&#44; debemos considerar que las tasas de hemorragia y recurrencia en pacientes con AVK se relacionan con el grado de control de la anticoagulaci&#243;n&#44; siendo m&#225;s bajas en aquellos con un tiempo dentro del rango terap&#233;utico &#40;TTR&#41; &#8805;<span class="elsevierStyleHsp" style=""></span>70&#37; &#40;RR&#58; 0&#44;50&#59; IC 95&#37;&#58; 0&#44;39-0&#44;63&#41; comparado con aquellos con TTR &#60;<span class="elsevierStyleHsp" style=""></span>30&#37;<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a>&#46; Por todo esto&#44; el reto actual se focaliza en elegir el f&#225;rmaco m&#225;s eficaz y seguro para extender la anticoagulaci&#243;n&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Reducci&#243;n de la enfermedad tromboemb&#243;lica venosa recurrente con anticoagulaci&#243;n extendida&#46; Eficacia</span><p id="par0075" class="elsevierStylePara elsevierViewall">La anticoagulaci&#243;n extendida con AVK reduce la ETEV recurrente en un 90&#37; &#40;RR&#58; 0&#44;12&#59; IC 95&#37;&#58; 0&#44;05-0&#44;25&#41;&#44; sucediendo la mitad de las recurrencias en los pacientes que suspendieron prematuramente el tratamiento<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a>&#46; Adem&#225;s&#44; este tratamiento reduce en un 50&#37; el resultado combinado de &#171;ETEV recurrente&#44; hemorragia mayor y muerte&#187; en comparaci&#243;n con la ausencia de anticoagulaci&#243;n<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#46; Estos resultados avalan la eficacia del tratamiento prolongado<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">23&#44;29</span></a>&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">Se han demostrado reducciones similares de recurrencia &#40;&#62;<span class="elsevierStyleHsp" style=""></span>80-92&#37;&#41; con anticoagulaci&#243;n extendida utilizando anticoagulantes orales de acci&#243;n directa &#40;ACOD&#41; frente a placebo<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30-32</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">tabla 2</a>&#41;&#46; Las heparinas de bajo peso molecular &#40;HBPM&#41; son tambi&#233;n muy eficaces<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">33</span></a>&#44; especialmente en pacientes con c&#225;ncer&#44; en quienes son preferibles al empleo de AVK<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">34</span></a>&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Reducci&#243;n de la hemorragia mayor con anticoagulaci&#243;n extendida&#46; Seguridad</span><p id="par0085" class="elsevierStylePara elsevierViewall">La anticoagulaci&#243;n con AVK se asocia con un aumento del riesgo de hemorragia mayor &#40;RR&#58; 2&#44;63&#59; IC 95&#37;&#58; 1&#44;02-6&#44;78&#41;<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">35</span></a>&#46; Los ACOD se han comparado con AVK para el tratamiento extendido de la ETEV<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30-36</span></a> y han demostrado ser igualmente eficaces&#44; pero m&#225;s seguros&#44; ya que se asocian con menos hemorragias mayores&#44; con la mitad de hemorragias intracraneales y una reducci&#243;n m&#225;s peque&#241;a de hemorragia extracraneal&#46; Por tanto&#44; aunque el tipo de anticoagulante no debe ser decisorio en la elecci&#243;n de la duraci&#243;n del tratamiento&#44; los ACOD suponen una alternativa m&#225;s segura para la prolongaci&#243;n de la anticoagulaci&#243;n &#40;<a class="elsevierStyleCrossRef" href="#tbl0015">tabla 3</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">Se han investigado otros f&#225;rmacos no anticoagulantes en la prevenci&#243;n de recurrencias de ETEV&#44; como el &#225;cido acetilsalic&#237;lico &#40;AAS&#41;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> y la sulodexida<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a>&#46; La eficacia ha sido menor&#44; con una reducci&#243;n de recurrencias del 30 y 50&#37;&#44; respectivamente&#59; y en el caso del AAS&#44; con tasas de hemorragia similares a las de algunos de los ACOD<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a>&#46; Por ello&#44; no son una alternativa para los pacientes sin contraindicaci&#243;n para la anticoagulaci&#243;n&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">&#191;Anticoagulaci&#243;n extendida&#63; A favor</span><p id="par0095" class="elsevierStylePara elsevierViewall">La decisi&#243;n m&#225;s dif&#237;cil en la ETEV no es la de anticoagular&#44; ni a qui&#233;n&#44; o qu&#233; tratamiento utilizar&#44; sino cu&#225;ndo suspender los anticoagulantes a un paciente despu&#233;s de un tiempo limitado de tratamiento&#46; Antes de decidir finalizar o extender la anticoagulaci&#243;n a un paciente con ETEV debemos recordar que&#58;<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">-</span><p id="par0100" class="elsevierStylePara elsevierViewall">El riesgo de recurrencia de trombosis se mantiene toda la vida del paciente y&#44; aunque es mayor en la ETEV idiop&#225;tica&#44; tambi&#233;n existe en la &#171;provocada&#187;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">-</span><p id="par0105" class="elsevierStylePara elsevierViewall">La tasa de mortalidad por recurrencia de ETEV es del 3-18&#37;&#46; Las recurrencias no mortales tambi&#233;n son relevantes &#40;SPT&#44; insuficiencia cardiaca y respiratoria&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">-</span><p id="par0110" class="elsevierStylePara elsevierViewall">El riesgo de hemorragia &#40;principal obst&#225;culo para mantener la anticoagulaci&#243;n&#41; es secundario&#44; por ser dif&#237;cil de predecir y por tener que asumirse cuando el riesgo de recurrencia es elevado&#46;</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">-</span><p id="par0115" class="elsevierStylePara elsevierViewall">La reducci&#243;n de ETEV recurrente con AVK &#40;90&#37;&#41;<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> avala la eficacia del tratamiento anticoagulante prolongado&#46;</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">-</span><p id="par0120" class="elsevierStylePara elsevierViewall">Se han objetivado reducciones similares de las recurrencias &#40;&#62;<span class="elsevierStyleHsp" style=""></span>80-92&#37;&#41; con anticoagulaci&#243;n extendida con ACOD<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30-32</span></a>&#46;</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">-</span><p id="par0125" class="elsevierStylePara elsevierViewall">En los pacientes en tratamiento con AVK el riesgo de recurrencia y de hemorragia se relaciona con el mal control de la anticoagulaci&#243;n&#46;</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">-</span><p id="par0130" class="elsevierStylePara elsevierViewall">En el tratamiento extendido los ACOD han demostrado ser igualmente eficaces que los AVK&#44; pero m&#225;s seguros &#40;menos hemorragias mayores y menos intracraneales&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">-</span><p id="par0135" class="elsevierStylePara elsevierViewall">Los ACOD no necesitan ajuste de dosis y disminuyen otros inconvenientes de la anticoagulaci&#243;n con AVK &#40;p&#46; ej&#46;&#44; control de laboratorio&#44; interacci&#243;n con f&#225;rmacos y alimentos&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">-</span><p id="par0140" class="elsevierStylePara elsevierViewall">No existen f&#225;rmacos alternativos a los anticoagulantes tan eficaces en la prevenci&#243;n de recurrencias que est&#233;n exentos de riesgo hemorr&#225;gico&#46;</p></li></ul></p><p id="par0145" class="elsevierStylePara elsevierViewall">Por &#250;ltimo&#44; es importante recordar que la elecci&#243;n de prolongar la anticoagulaci&#243;n debe individualizarse siempre en funci&#243;n de las caracter&#237;sticas del paciente&#46; La decisi&#243;n de proceder a una &#171;anticoagulaci&#243;n extendida&#187; no es sin&#243;nimo de &#171;anticoagulaci&#243;n para siempre&#187;&#46; En todos los pacientes que reciben anticoagulaci&#243;n prolongada se debe reevaluar peri&#243;dicamente el riesgo y beneficio de continuar con el tratamiento&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conflicto de intereses</span><p id="par0150" class="elsevierStylePara elsevierViewall">La autora declara no tener ning&#250;n conflicto de intereses&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:11 [
        0 => array:3 [
          "identificador" => "xres875395"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec863567"
          "titulo" => "Palabras clave"
        ]
        2 => array:3 [
          "identificador" => "xres875394"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec863566"
          "titulo" => "Keywords"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Riesgo de recurrencia y de hemorragia"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Balance del riesgo-beneficio de extender la anticoagulaci&#243;n"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Reducci&#243;n de la enfermedad tromboemb&#243;lica venosa recurrente con anticoagulaci&#243;n extendida&#46; Eficacia"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Reducci&#243;n de la hemorragia mayor con anticoagulaci&#243;n extendida&#46; Seguridad"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "&#191;Anticoagulaci&#243;n extendida&#63; A favor"
        ]
        9 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Conflicto de intereses"
        ]
        10 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2017-01-02"
    "fechaAceptado" => "2017-02-23"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec863567"
          "palabras" => array:6 [
            0 => "Enfermedad tromboemb&#243;lica venosa"
            1 => "No provocado"
            2 => "Recurrencia"
            3 => "Hemorragia"
            4 => "Anticoagulaci&#243;n extendida"
            5 => "Anticoagulantes"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec863566"
          "palabras" => array:6 [
            0 => "Venous thromboembolism disease"
            1 => "Unprovoked"
            2 => "Recurrence"
            3 => "Haemorrhage"
            4 => "Extended anticoagulation"
            5 => "Anticoagulants"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La enfermedad tromboemb&#243;lica venosa puede considerarse una enfermedad cr&#243;nica ya que&#44; tras un primer episodio&#44; el riesgo de recurrencia permanece toda la vida&#46; La recurrencia es una complicaci&#243;n grave&#46; La anticoagulaci&#243;n es eficaz mientras se mantiene&#44; pero al suspenderla el riesgo de nuevos eventos tromb&#243;ticos persiste indefinidamente&#46; Las gu&#237;as de pr&#225;ctica cl&#237;nica ofrecen recomendaciones espec&#237;ficas sobre la duraci&#243;n del tratamiento en pacientes con enfermedad provocada o recurrente&#44; pero son poco precisas para aquellos con un primer episodio no provocado&#46; La decisi&#243;n debe tomarse tras una cuidadosa valoraci&#243;n individual del riesgo-beneficio de la anticoagulaci&#243;n&#46; Este art&#237;culo repasa las evidencias a favor de prolongar la anticoagulaci&#243;n y las opciones terap&#233;uticas actuales&#46;</p></span>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Venous thromboembolism disease can be considered a chronic disease because&#44; after the first episode&#44; there is a life-long risk of recurrence&#46; Recurrence is a severe complication&#46; Anticoagulation is effective while it is maintained&#44; but when it is discontinued&#44; the risk of new thrombotic events persists indefinitely&#46; Clinical practice guidelines offer specific recommendations on the treatment duration for patients with provoked or recurrent disease but are not specific for those with a first unprovoked episode&#46; The decision should be made after a careful individual assessment of the risk-benefit of anticoagulation&#46; This article reviews the evidence in favour of extending the anticoagulation and the current therapeutic options&#46;</p></span>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:2 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Riesgo general de recurrencia estimado<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">en 5 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pacientes con ETEV &#40;TVP proximal o EP&#41; provocada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Mujeres con d&#237;mero-D negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Varones con d&#237;mero-D negativo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pacientes con ETEV &#40;TVP proximal o EP&#41; idiop&#225;tica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">30&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1477609.png"
              ]
            ]
            1 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Riesgo general de recurrencia estimado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">en 10 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ETEV secundaria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Episodio grave de EP&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">30&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ETEV idiop&#225;tica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1477606.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Los pacientes con un segundo episodio de ETEV tienen un riesgo de recurrencia de aproximadamente un 50&#37; mayor que los que tienen un episodio&#46;</p> <p class="elsevierStyleNotepara" id="npar0010">EP&#58; embolia pulmonar&#59; ETEV&#58; enfermedad tromboemb&#243;lica venosa&#59; TVP&#58; trombosis venosa profunda&#59;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Riesgo de recurrencia estimado de enfermedad tromboemb&#243;lica venosa</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabla 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Tratamiento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Duraci&#243;n tratamiento &#40;meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hemorragia mayor &#40;eventos&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Riesgo recurrencia frente a placebo HR &#40;IC 95&#37;&#41;&#59; p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Riesgo hemorragia cl&#237;nicamente relevante<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a> frente a placebo HR &#40;IC 95&#37;&#41;&#59; p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">PADIS<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">AVK&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">18&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;15<br>&#40;0&#44;51-0&#44;90&#41; p<span class="elsevierStyleHsp" style=""></span>&#8804;<span class="elsevierStyleHsp" style=""></span>0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&#44;96<br>&#40;0&#44;19-9&#44;35&#41; p <span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;22&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">RE-SONATE<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Dabigatr&#225;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;08<br>&#40;0&#44;02-0&#44;25&#41; p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;01&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;92<br>&#40;1&#44;52-5&#44;60&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">EINSTEIN-EXT<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Rivaroxab&#225;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;18<br>&#40;0&#44;09-0&#44;39&#41; p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&#44;19<br>&#40;2&#44;13-11&#44;7&#41; p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">AMPLIFY-EXT<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Apixab&#225;n &#40;2&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;19<br>&#40;0&#44;11-0&#44;33&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;20<br>&#40;0&#44;69-2&#44;10&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">AMPLIFY-EXT<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Apixab&#225;n &#40;5<span class="elsevierStyleHsp" style=""></span>mg&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;20<br>&#40;0&#44;11-0&#44;34&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;62<br>&#40;0&#44;96-2&#44;73&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ASPIRE-WARFASA<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#193;cido acetilsalic&#237;lico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24 &#40;48&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;68<br>&#40;0&#44;51-0&#44;90&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;50<br>&#40;0&#44;72-3&#44;14&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;28&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SURVET<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sulodexida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;45<br>&#40;0&#44;27-0&#44;92&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;02&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;97<br>&#40;0&#44;14-6&#44;88&#41; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;98&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1477607.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Mayor o no mayor cl&#237;nicamente relevante&#46;</p> <p class="elsevierStyleNotepara" id="npar0020">p nd&#58; valor de probabilidad no disponible en el art&#237;culo original&#46;</p> <p class="elsevierStyleNotepara" id="npar0025">AVK&#58; antivitamina K&#59; HR&#58; <span class="elsevierStyleItalic">Hazard Ratio</span>&#59; IC-95&#37;&#58; intervalo de confianza al 95&#37;&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Estudios en prevenci&#243;n de recurrencia de enfermedad tromboemb&#243;lica venosa</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Tabla 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">ACOD vs AVK&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">N&#250;mero de pacientes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Mortalidad global&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Recurrencia<br>&#40;IC-95&#37;&#41;p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hemorragia mayor<br>&#40;IC-95&#37;&#41;p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hemorragia cl&#237;nicamente relevante<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">&#42;</span></a><br>&#40;IC-95&#37;&#41;p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hemorragia<br>intracraneal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dabigatran<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a><br>RE-MEDY&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#46;856&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;89<br>&#40;0&#44;47-1&#44;71&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;44<br>&#40;0&#44;79-2&#46;62&#41; p 0&#44;01&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;52<br>&#40;0&#44;27-1&#44;01&#41; p 0&#44;06&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;54<br>&#40;0&#44;41-0&#44;71&#41; p&#60;0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Eventos 2 vs&#46; 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Edoxaban<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a><br>HOKUSAI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&#46;118&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;97<br>&#40;0&#44;69-1&#44;38&#41;<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">&#42;&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;45<br>&#40;0&#44;22-0&#44;92&#41;<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">&#42;&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;97<br>&#40;0&#44;77-1&#44;22&#41;<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">&#42;&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;16<br>&#40;0&#44;02-1&#44;36&#41;<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">&#42;&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1477608.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Mayor o no mayor cl&#237;nicamente relevante&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0020"
              "etiqueta" => "&#42;&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0035">La significaci&#243;n estad&#237;stica &#40;valor de p&#41; no est&#225; disponible en el art&#237;culo original&#46;</p> <p class="elsevierStyleNotepara" id="npar0040">ACOD&#58; anticoagulantes orales de acci&#243;n directa&#59; AVK&#58; antivitamina K&#59; HR&#58; <span class="elsevierStyleItalic">Hazard Ratio</span>&#59; IC-95&#37;&#58; intervalo de confianza al 95&#37;&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Anticoagulantes orales de acci&#243;n directa frente a antivitamina K en el tratamiento extendido de la enfermedad tromboemb&#243;lica venosa</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:38 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46; Pengo"
                            1 => "A&#46;W&#46; Lensing"
                            2 => "M&#46;H&#46; Prins"
                            3 => "A&#46; Marchiori"
                            4 => "B&#46;L&#46; Davidson"
                            5 => "F&#46; Tiozzo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa032274"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2004"
                        "volumen" => "350"
                        "paginaInicial" => "2257"
                        "paginaFinal" => "2264"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15163775"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The long-term clinical course of acute deep venous thrombosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Prandoni"
                            1 => "A&#46;W&#46; Lensing"
                            2 => "A&#46; Congo"
                            3 => "S&#46; Cuppini"
                            4 => "S&#46; Villalta"
                            5 => "M&#46; Carta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Intern Med&#46;"
                        "fecha" => "1996"
                        "volumen" => "125"
                        "paginaInicial" => "1"
                        "paginaFinal" => "7"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8644983"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor&#58; a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Iorio"
                            1 => "C&#46; Kearon"
                            2 => "E&#46; Filippucci"
                            3 => "M&#46; Marcucci"
                            4 => "A&#46; Macura"
                            5 => "V&#46; Pengo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archinternmed.2010.367"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med&#46;"
                        "fecha" => "2010"
                        "volumen" => "170"
                        "paginaInicial" => "1710"
                        "paginaFinal" => "1716"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20975016"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism&#46; A prospective cohort study in 1&#44;626 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Prandoni"
                            1 => "F&#46; Noventa"
                            2 => "A&#46; Ghirarduzzi"
                            3 => "V&#46; Pengo"
                            4 => "E&#46; Bernardi"
                            5 => "R&#46; Pesavento"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Haematologica"
                        "fecha" => "2007"
                        "volumen" => "92"
                        "paginaInicial" => "199"
                        "paginaFinal" => "205"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17296569"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;D&#46; Douketis"
                            1 => "C&#46;S&#46; Gu"
                            2 => "S&#46; Schulman"
                            3 => "A&#46; Ghirarduzzi"
                            4 => "V&#46; Pengo"
                            5 => "P&#46; Prandoni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Intern Med&#46;"
                        "fecha" => "2007"
                        "volumen" => "147"
                        "paginaInicial" => "766"
                        "paginaFinal" => "774"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18056660"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antithrombotic therapy for VTE disease&#58; CHEST guideline and expert panel report"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kearon"
                            1 => "E&#46;A&#46; Akl"
                            2 => "J&#46; Ornelas"
                            3 => "A&#46; Blaivas"
                            4 => "D&#46; Jimenez"
                            5 => "H&#46; Bounameaux"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.chest.2015.11.026"
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest"
                        "fecha" => "2016"
                        "volumen" => "149"
                        "paginaInicial" => "315"
                        "paginaFinal" => "352"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26867832"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology &#40;ESC&#41;&#46; 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;V&#46; Konstantinides"
                            1 => "A&#46; Torbicki"
                            2 => "G&#46; Agnelli"
                            3 => "N&#46; Danchin"
                            4 => "D&#46; Fitzmaurice"
                            5 => "N&#46; Galie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehu283"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Heart J&#46;"
                        "fecha" => "2014"
                        "volumen" => "35"
                        "paginaInicial" => "3033"
                        "paginaFinal" => "3069"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25173341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Kearon"
                            1 => "E&#46;A&#46; Akl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2013-12-512681"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2014"
                        "volumen" => "123"
                        "paginaInicial" => "1794"
                        "paginaFinal" => "1801"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24497538"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment&#58; analysis of individual participants&#8217; data from seven trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Boutitie"
                            1 => "L&#46; Pinede"
                            2 => "S&#46; Schulman"
                            3 => "G&#46; Agnelli"
                            4 => "G&#46; Raskob"
                            5 => "J&#46; Julian"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ&#46;"
                        "fecha" => "2011"
                        "volumen" => "342"
                        "paginaInicial" => "d3036"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21610040"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "PROLONG Investigators&#46; D-dimer testing to determine the duration of anticoagulation therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46; Palareti"
                            1 => "B&#46; Cosmi"
                            2 => "C&#46; Legnani"
                            3 => "A&#46; Tosetto"
                            4 => "C&#46; Brusi"
                            5 => "A&#46; Iorio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa054444"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2006"
                        "volumen" => "355"
                        "paginaInicial" => "1780"
                        "paginaFinal" => "1789"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17065639"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism&#58; the PROLONG II prospective study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "B&#46; Cosmi"
                            1 => "C&#46; Legnani"
                            2 => "A&#46; Tosetto"
                            3 => "V&#46; Pengo"
                            4 => "A&#46; Ghirarduzzi"
                            5 => "S&#46; Testa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2009-08-237354"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2010"
                        "volumen" => "115"
                        "paginaInicial" => "481"
                        "paginaFinal" => "488"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19965693"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis&#58; the duration of anticoagulation based on compression ultrasonography &#40;DACUS&#41; study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "S&#46; Siragusa"
                            1 => "A&#46; Malato"
                            2 => "R&#46; Anastasio"
                            3 => "V&#46; Cigna"
                            4 => "G&#46; Milio"
                            5 => "C&#46; Amato"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2008-01-131656"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2008"
                        "volumen" => "112"
                        "paginaInicial" => "511"
                        "paginaFinal" => "515"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18497320"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism&#58; a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "D&#46; Garcia"
                            1 => "E&#46;A&#46; Akl"
                            2 => "R&#46; Carr"
                            3 => "C&#46; Kearon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2013-04-496257"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2013"
                        "volumen" => "122"
                        "paginaInicial" => "817"
                        "paginaFinal" => "824"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23760616"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence&#63;&#46; A patient-level meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "T&#46; Baglin"
                            1 => "J&#46; Douketis"
                            2 => "A&#46; Tosetto"
                            3 => "M&#46; Marcucci"
                            4 => "M&#46; Cushman"
                            5 => "P&#46; Kyrle"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2010"
                        "volumen" => "8"
                        "paginaInicial" => "2436"
                        "paginaFinal" => "2442"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46;A&#46; Rodger"
                            1 => "S&#46;R&#46; Kahn"
                            2 => "P&#46;S&#46; Wells"
                            3 => "D&#46;A&#46; Anderson"
                            4 => "I&#46; Chagnon"
                            5 => "G&#46; Le Gal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1503/cmaj.080493"
                      "Revista" => array:6 [
                        "tituloSerie" => "CMAJ&#46;"
                        "fecha" => "2008"
                        "volumen" => "179"
                        "paginaInicial" => "417"
                        "paginaFinal" => "426"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18725614"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Predicting disease recurrence in patients with previous unprovoked venous thromboembolism&#46; A proposed prediction score &#40;DASH&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Tosetto"
                            1 => "A&#46; Iorio"
                            2 => "M&#46; Marcucci"
                            3 => "T&#46; Baglin"
                            4 => "M&#46; Cushman"
                            5 => "S&#46; Eichinger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2012"
                        "volumen" => "10"
                        "paginaInicial" => "1019"
                        "paginaFinal" => "1025"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism&#58; the Vienna prediction model"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "S&#46; Eichinger"
                            1 => "G&#46; Heinze"
                            2 => "L&#46;M&#46; Jandeck"
                            3 => "P&#46;A&#46; Kyrle"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.109.925214"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2010"
                        "volumen" => "121"
                        "paginaInicial" => "1630"
                        "paginaFinal" => "1636"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20351233"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "C&#46; Kearon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2009"
                        "volumen" => "7"
                        "numero" => "Suppl&#46; 1"
                        "paginaInicial" => "296"
                        "paginaFinal" => "300"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical impact of bleeding in patients taking oral anticoagulation for venous thromboembolism&#46; A meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46;A&#46; Linkis"
                            1 => "P&#46;T&#46; Choi"
                            2 => "D&#46; Duketis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Ann Inter Med&#46;"
                        "fecha" => "2003"
                        "volumen" => "139"
                        "paginaInicial" => "893"
                        "paginaFinal" => "900"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical outcome of patients with major bleeding after venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Nieto"
                            1 => "T&#46; C&#225;mara"
                            2 => "E&#46; Gonz&#225;lez-Higueras"
                            3 => "N&#46; Ruiz Jim&#233;nez"
                            4 => "R&#46; Guijarro"
                            5 => "P&#46;J&#46; Marchena"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "ThrombHaemost&#46;"
                        "fecha" => "2008"
                        "volumen" => "100"
                        "paginaInicial" => "789"
                        "paginaFinal" => "796"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Three months versus one year of oral anticoagulant therapy for idiopathic deep vein thrombosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "AgnelliG"
                            1 => "P&#46; Prandoni"
                            2 => "M&#46;G&#46; Santamaria"
                            3 => "P&#46; Bagatella"
                            4 => "A&#46; Iorio"
                            5 => "M&#46; Bazzan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Eng J Med&#46;"
                        "fecha" => "2001"
                        "volumen" => "345"
                        "paginaInicial" => "165"
                        "paginaFinal" => "169"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kearon"
                            1 => "M&#46; Gent"
                            2 => "J&#46; Hirsh"
                            3 => "J&#46; Weitz"
                            4 => "M&#46;J&#46; Kovacs"
                            5 => "D&#46;R&#46; Anderson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM199903253401201"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "1999"
                        "volumen" => "340"
                        "paginaInicial" => "901"
                        "paginaFinal" => "907"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10089183"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "For the PREVENT investigators&#46; Long-term&#44; low-intensity warfarin therapy for prevention of recurrent venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46;M&#46; Ridker"
                            1 => "S&#46;Z&#46; Goldhaber"
                            2 => "E&#46; Danielson"
                            3 => "Y&#46; Rosenberg"
                            4 => "C&#46;S&#46; Eby"
                            5 => "S&#46;R&#46; Deitcher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Eng J Med"
                        "fecha" => "2003"
                        "volumen" => "348"
                        "paginaInicial" => "1425"
                        "paginaFinal" => "1434"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Duration of anticoagulation following venous thromboembolism&#58; a meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "D&#46; Ost"
                            1 => "J&#46; Tepper"
                            2 => "H&#46; Mihara"
                            3 => "O&#46; Lander"
                            4 => "R&#46; Heinzer"
                            5 => "A&#46; Fein"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.294.6.706"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2005"
                        "volumen" => "294"
                        "paginaInicial" => "706"
                        "paginaFinal" => "715"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16091573"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Post-thrombotic syndrome&#44; recurrence&#44; and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Schulman"
                            1 => "P&#46; Lindmarker"
                            2 => "M&#46; Holmstrom"
                            3 => "G&#46; Larfars"
                            4 => "A&#46; Carlsson"
                            5 => "P&#46; Nicol"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2006"
                        "volumen" => "4"
                        "paginaInicial" => "734"
                        "paginaFinal" => "742"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kearon"
                            1 => "J&#46;S&#46; Ginsberg"
                            2 => "M&#46;J&#46; Kovacs"
                            3 => "D&#46;R&#46; Anderson"
                            4 => "P&#46;S&#46; Wells"
                            5 => "J&#46;A&#46; Julian"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa035422"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2003"
                        "volumen" => "349"
                        "paginaInicial" => "631"
                        "paginaFinal" => "639"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12917299"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of outcomes after hospitalization for deep vein thrombosis or pulmonary embolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; Murin"
                            1 => "P&#46;S&#46; Romano"
                            2 => "R&#46;H&#46; White"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "ThrombHaemost&#46;"
                        "fecha" => "2002"
                        "volumen" => "88"
                        "paginaInicial" => "407"
                        "paginaFinal" => "414"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Quality of INR control and outcomes following venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46;M&#46; Gallagher"
                            1 => "F&#46; Vries"
                            2 => "J&#46;M&#46; Plumb"
                            3 => "B&#46; Ha&#223;"
                            4 => "A&#46; Clemens"
                            5 => "T&#46;P&#46; van Staa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "ClinApplThrombHemost&#46;"
                        "fecha" => "2012"
                        "volumen" => "18"
                        "paginaInicial" => "370"
                        "paginaFinal" => "378"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Six months vs extended oral anticoagulation after a first episode of pulmonary embolism&#58; The PADIS-PE randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "PADIS-PE Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Couturaud"
                            1 => "O&#46; Sanchez"
                            2 => "G&#46; Pernod"
                            3 => "P&#46; Mismetti"
                            4 => "P&#46; Jego"
                            5 => "E&#46; Duhamel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2015.7046"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2015"
                        "volumen" => "314"
                        "paginaInicial" => "31"
                        "paginaFinal" => "40"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26151264"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "RE-SONATE trial investigators&#46; Extended use of dabigatran&#44; warfarin&#44; or placebo in venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "RE-MEDY trial investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Schulman"
                            1 => "C&#46; Kearon"
                            2 => "A&#46;K&#46; Kakkar"
                            3 => "S&#46; Schellong"
                            4 => "H&#46; Eriksson"
                            5 => "D&#46; Baanstra"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1113697"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2013"
                        "volumen" => "368"
                        "paginaInicial" => "709"
                        "paginaFinal" => "718"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23425163"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Oral rivaroxaban after symptomatic venous thromboembolism&#58; the continued treatment study &#40;EINSTEIN-extension study&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "E&#46; Romualdi"
                            1 => "M&#46;P&#46; Donadini"
                            2 => "W&#46; Agerno"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Expert Rev CardiovascTher&#46;"
                        "fecha" => "2011"
                        "volumen" => "9"
                        "paginaInicial" => "841"
                        "paginaFinal" => "844"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Apixaban for extended treatment of venous thromboembolism"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "for the AMPLIFY-EXT Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Agnelli"
                            1 => "H&#46;R&#46; Buller"
                            2 => "A&#46; Cohen"
                            3 => "M&#46; Curto"
                            4 => "A&#46;S&#46; Gallus"
                            5 => "M&#46; Johnson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/ NEJMoa1207541"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2013"
                        "volumen" => "368"
                        "paginaInicial" => "699"
                        "paginaFinal" => "708"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23216615"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis&#58; a systematic review and meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46; Carrier"
                            1 => "C&#46; Cameron"
                            2 => "A&#46; Delluc"
                            3 => "L&#46; Castellucci"
                            4 => "A&#46;A&#46; Khorana"
                            5 => "A&#46;Y&#46; Lee"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.thromres.2014.09.039"
                      "Revista" => array:6 [
                        "tituloSerie" => "Thromb Res&#46;"
                        "fecha" => "2014"
                        "volumen" => "134"
                        "paginaInicial" => "1214"
                        "paginaFinal" => "1219"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25457583"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer&#58; a randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;Y&#46; Lee"
                            1 => "P&#46;W&#46; Kamphuisen"
                            2 => "G&#46; Meyer"
                            3 => "R&#46; Bauersachs"
                            4 => "M&#46;S&#46; Janas"
                            5 => "M&#46;F&#46; Jarner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2015.9243"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2015"
                        "volumen" => "314"
                        "paginaInicial" => "677"
                        "paginaFinal" => "686"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26284719"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiology and management of bleeding in patients using vitamin K antagonists"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46; Levi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J ThrombHaemost&#46;"
                        "fecha" => "2009"
                        "volumen" => "7"
                        "numero" => "Suppl&#46;1"
                        "paginaInicial" => "103"
                        "paginaFinal" => "106"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism&#58; A post- hoc analysis of the Hokusai-VTE study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Raskob"
                            1 => "W&#46; Ageno"
                            2 => "A&#46;T&#46; Cohen"
                            3 => "M&#46;P&#46; Brekelmans"
                            4 => "M&#46;A&#46; Grosso"
                            5 => "A&#46; Segers"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Lancet Haematol&#46;"
                        "fecha" => "2016"
                        "volumen" => "3"
                        "paginaInicial" => "228"
                        "paginaFinal" => "236"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Aspirin for the prevention of recurrent venous thromboembolism&#58; the INSPIRE collaboration"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "INSPIRE Study Investigators &#40;International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism&#41;"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Simes"
                            1 => "C&#46; Becattini"
                            2 => "G&#46; Agnelli"
                            3 => "J&#46;W&#46; Eikelboom"
                            4 => "A&#46;C&#46; Kirby"
                            5 => "R&#46; Mister"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.114.008828"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2014"
                        "volumen" => "130"
                        "paginaInicial" => "1062"
                        "paginaFinal" => "1071"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25156992"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The sulodexide in secondary prevention of recurrent deep vein thrombosis &#40;SURVET&#41; study&#58; A multicenter&#44; randomized&#44; double blind&#44; placebo- controlled trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "on belhaf of the SURVET Study investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46;M&#46; Andreozzi"
                            1 => "A&#46;A&#46; Bignamini"
                            2 => "G&#46; Davi"
                            3 => "G&#46; Palareti"
                            4 => "J&#46; Matuska"
                            5 => "M&#46; Holy"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.115.016930"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2015"
                        "volumen" => "132"
                        "paginaInicial" => "1891"
                        "paginaFinal" => "1897"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26408273"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00142565/0000021700000006/v1_201707280054/S0014256517300978/v1_201707280054/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66382"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Pros y Contras"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00142565/0000021700000006/v1_201707280054/S0014256517300978/v1_201707280054/es/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256517300978?idApp=WRCEE"
]
Información del artículo
ISSN: 00142565
Idioma original: Español
Datos actualizados diariamente
año/Mes Html Pdf Total
2023 Marzo 2 11 13
2019 Marzo 1 0 1
2018 Octubre 2 1 3
2018 Agosto 3 0 3
2018 Junio 1 0 1
2018 Mayo 0 1 1
2018 Febrero 0 1 1
2018 Enero 0 1 1
2017 Diciembre 1 1 2
2017 Noviembre 1 5 6
2017 Octubre 7 3 10
2017 Septiembre 15 5 20
2017 Agosto 37 13 50
2017 Julio 11 7 18
2017 Junio 0 3 3
2017 Mayo 0 4 4
2017 Abril 0 6 6
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Revista Clínica Española
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?